<SEC-DOCUMENT>0001193125-26-085507.txt : 20260302
<SEC-HEADER>0001193125-26-085507.hdr.sgml : 20260302
<ACCEPTANCE-DATETIME>20260302163015
ACCESSION NUMBER:		0001193125-26-085507
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20260225
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260302
DATE AS OF CHANGE:		20260302

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LifeStance Health Group, Inc.
		CENTRAL INDEX KEY:			0001845257
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40478
		FILM NUMBER:		26708193

	BUSINESS ADDRESS:	
		STREET 1:		4800 N. SCOTTSDALE ROAD
		STREET 2:		SUITE 2500
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85251
		BUSINESS PHONE:		602-767-2100

	MAIL ADDRESS:	
		STREET 1:		4800 N. SCOTTSDALE ROAD
		STREET 2:		SUITE 2500
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85251
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d116309d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lfst="http://lifestance.com/20260225" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-295">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2026-02-25_to_2026-02-25">0001845257</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="lfst-20260225.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2026-02-25_to_2026-02-25"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001845257</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-02-25</xbrli:startDate> <xbrli:endDate>2026-02-25</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-306">8-K</ix:nonNumeric></span></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt:datemonthdayyearen" id="ixv-307">February&#160;25, 2026</ix:nonNumeric></p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-308">LifeStance Health Group, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:stateprovnameen" id="ixv-309">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-310">001-40478</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-311">86-1832801</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-312">4800 N. Scottsdale Road</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-313">Suite 2500</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-314">Scottsdale</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:stateprovnameen" id="ixv-315">Arizona</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-316">85251</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-317">602</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-318">767-2100</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:boolballotbox" id="ixv-319">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:boolballotbox" id="ixv-320">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:boolballotbox" id="ixv-321">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:boolballotbox" id="ixv-322">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-323">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-324">LFST</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:exchnameen" id="ixv-325">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#160;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2026-02-25_to_2026-02-25" format="ixt-sec:boolballotbox" id="ixv-326">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&#160;25, 2026, LifeStance Health Group, Inc. (the &#8220;<span style="text-decoration:underline">Company</span>&#8221;) entered into an Underwriting Agreement (the &#8220;<span style="text-decoration:underline">Underwriting Agreement</span>&#8221;) by and among the Company, J.P. Morgan Securities LLC (the &#8220;<span style="text-decoration:underline">Underwriter</span>&#8221;), and the selling stockholders named in Schedule II thereto (the &#8220;<span style="text-decoration:underline">Selling Stockholders</span>&#8221;), relating to the underwritten offering of 25,000,000&#160;shares (the &#8220;<span style="text-decoration:underline">Shares</span>&#8221;) of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;<span style="text-decoration:underline">Common Stock</span>&#8221;), pursuant to the Company&#8217;s registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-279585),</span> filed on May&#160;21, 2024 (the &#8220;<span style="text-decoration:underline">Registration Statement</span>&#8221;). In addition, pursuant to the Underwriting Agreement, the Company has agreed to purchase from the Underwriter 7,000,000 Shares sold by the Selling Stockholder to the Underwriter, at a price per share equal to the price per share paid by the Underwriter to the Selling Stockholder. The Underwriter did not receive any compensation for shares of the Common Stock being repurchased by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the Shares are being sold by the Selling Stockholders. The Company did not receive any proceeds from the offering. The closing of the offering occurred on March&#160;2, 2026. The description of the Underwriting Agreement is qualified in its entirety by the terms of such agreement, which is incorporated herein by reference and attached to this report as Exhibit&#160;1.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ropes&#160;&amp; Gray LLP, counsel to the Company, has issued an opinion to the Company regarding the Shares sold in the offering. A copy of the opinion is filed as Exhibit 5.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K.</span></p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d116309dex11.htm">Underwriting Agreement, dated February&#160;25, 2026, by and among the Company, the Underwriter and the Selling Stockholders. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d116309dex51.htm">Opinion of Ropes&#160;&amp; Gray LLP </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d116309dex51.htm">Consent of Ropes&#160;&amp; Gray LLP (included in Exhibit&#160;5.1 above) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">LifeStance Health Group, Inc.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: March&#160;2, 2026</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">/s/ Ryan McGroarty</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"><span style="font-weight:bold">Ryan McGroarty</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d116309dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 1.1 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXECUTION VERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>25,000,000 SHARES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIFESTANCE HEALTH GROUP, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMON STOCK, PAR VALUE $0.01 PER SHARE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDERWRITING AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">February 25, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">270 Park Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stockholders listed
in Schedule II hereto (the &#8220;<B>Selling Stockholders</B>&#8221;) of LifeStance Health Group, Inc., a Delaware corporation (the &#8220;<B>Company</B>&#8221;), severally propose to sell to the Underwriter named in Schedule I hereto (the
&#8220;<B>Underwriter</B>&#8221;), an aggregate of 25,000,000 shares (the &#8220;<B>Shares</B>&#8221;) of the common stock, par value $0.01 per share, of the Company (the &#8220;<B>Common Stock</B>&#8221;), each Selling Stockholder selling the
amount set forth opposite such Selling Stockholder&#8217;s name in Schedule II hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the sale of the Shares by the Selling
Stockholders to the Underwriter in compliance with the terms of this Agreement, the Underwriter has agreed to sell to the Company, and the Company has agreed herein to purchase from the Underwriter (the &#8220;<B>Share Repurchase</B>&#8221;), an
aggregate of 7,000,000 shares of Common Stock (such shares, hereunder, the &#8220;<B>Repurchase Shares</B>&#8221;) pursuant to Section&nbsp;3 of this Agreement. The Shares other than the Repurchase Shares are herein called the &#8220;<B>Public
Offering Shares</B>.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has filed with the Securities and Exchange Commission (the &#8220;<B>Commission</B>&#8221;) an
automatic shelf registration statement on Form S-3 (File No.&nbsp;333-279585), including a base prospectus (the &#8220;<B>Base Prospectus</B>&#8221;), relating to the Shares. The registration statement, which became effective immediately upon
filing, as amended to the date of this agreement, including all documents incorporated or deemed to be incorporated by reference therein and the information (if any) deemed to be part of the registration statement at the time of effectiveness
pursuant to Rule&nbsp;430A or 430B under the Securities Act of 1933, as amended (the &#8220;<B>Securities Act</B>&#8221;), is hereinafter referred to as the &#8220;<B>Registration Statement</B>&#8221;; the prospectus in the form first used to
confirm sales of Shares (or in the form first made available to the Underwriter by the Company to meet requests of purchasers pursuant to Rule 173 under the Securities Act) together with the Base Prospectus is hereinafter referred to as the
&#8220;<B>Prospectus</B>.&#8221; If the Company has filed an abbreviated registration statement to register additional shares of Common Stock pursuant to Rule&nbsp;462(b) under the Securities Act (a &#8220;<B>Rule 462 Registration
Statement</B>&#8221;), then any reference herein to the term &#8220;<B>Registration Statement</B>&#8221; shall be deemed to include such Rule 462 Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, &#8220;<B>free writing prospectus</B>&#8221; has the meaning set forth in Rule 405 under the Securities Act,
&#8220;<B>preliminary prospectus</B>&#8221; shall mean each prospectus (including each preliminary prospectus supplement to the Base Prospectus) that omitted information pursuant to Rule 430A or 430B under the Securities Act that was used, together
with the Base Prospectus, after effectiveness of the Registration Statement and prior to the execution and delivery of this Agreement, &#8220;<B>Time of Sale Prospectus</B>&#8221; means the Base Prospectus contained in the Registration Statement at
the time of its effectiveness and the preliminary prospectus, together with the documents, pricing information and free writing prospectuses, if any, set forth in Schedule III hereto, and &#8220;<B>broadly available road show</B>&#8221; means a
&#8220;bona fide electronic road show&#8221; as defined in Rule 433(h)(5) under the Securities Act that has been made available without restriction to any person. As used herein, the terms &#8220;Registration Statement,&#8221; &#8220;preliminary
prospectus,&#8221; &#8220;Time of Sale Prospectus&#8221; and &#8220;Prospectus&#8221; shall include the documents, if any, incorporated by reference therein as of the date hereof. The terms &#8220;<B>supplement</B>&#8221;
&#8220;<B>amendment</B>&#8221; and &#8220;<B>amend</B>&#8221; as used herein with respect to the Registration Statement, the Prospectus, the Time of Sale Prospectus or the Prospectus shall include all documents subsequently filed by the Company with
the Commission pursuant to the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;), that are deemed to be incorporated by reference therein. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <I>Representations and Warranties of the Company</I>. The Company represents and warrants
to, and agrees with the Underwriter and each of the Selling Stockholders that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Registration Statement has become
effective; no stop order suspending the effectiveness of the Registration Statement is in effect, and no proceedings for such purpose or pursuant to Section&nbsp;8A under the Securities Act are pending before or, to the Company&#8217;s knowledge,
threatened by the Commission. The Registration Statement is an automatic shelf registration statement as defined in Rule 405 under the Securities Act and the Company is a well-known seasoned issuer (as defined in Rule 405 under the Securities Act)
eligible to use the Registration Statement as an automatic shelf registration statement and the Company has not received notice that the Commission objects to the Company&#8217;s use of the Registration Statement as an automatic shelf registration
statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) (i) Each document, if any, filed or to be filed pursuant to the Exchange Act and incorporated by reference
in the Time of Sale Prospectus or the Prospectus complied or will comply when so filed in all material respects with the Exchange Act and the applicable rules and regulations of the Commission thereunder; (ii)&nbsp;the Registration Statement, when
it became effective, did not contain and, as amended or supplemented, if applicable, will not, as of the date of such amendment or supplement, contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading; (iii)&nbsp;the Registration Statement and the Prospectus comply and, as amended or supplemented, if applicable, will comply, when filed, in all material respects with the Securities
Act and the applicable rules and regulations of the Commission thereunder; (iv)&nbsp;the Time of Sale Prospectus does not, and at the time of each sale of the Shares in connection with the offering when the Prospectus is not yet available to
prospective purchasers and at the Closing Date (as defined in Section&nbsp;5), the Time of Sale Prospectus, as then amended or supplemented by the Company, if applicable, will not, as of the filing date of such amendment or supplement, contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; (v)&nbsp;each broadly available road show, if any, when
considered together with the Time of Sale Prospectus, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading; and (vi)&nbsp;the Prospectus does not contain and, as amended or supplemented, if applicable, will not, as of the filing date of such amendment or supplement, contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and warranties set forth in this paragraph do not apply to statements or omissions
in the Registration Statement, the Time of Sale Prospectus or the Prospectus based upon information relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use therein, it being understood and agreed that the
only such information furnished by the Underwriter consists of the Underwriter Information (as defined in Section&nbsp;11(c) of this Agreement). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company is not an &#8220;ineligible issuer&#8221; as defined in Rules 164, 405 and 433 under the Securities Act. Any
free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules and
regulations of the Commission thereunder. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or referred to by the Company
complies or, if filed after the date of this Agreement, will comply, when filed, in all material respects with the requirements of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Securities Act and the applicable rules and regulations of the Commission thereunder. Except for the free writing prospectuses, if any, identified in Schedule III hereto, and electronic road
shows, if any, each furnished to the Underwriter before first use, the Company has not prepared, used or referred to, and will not, without the Underwriter&#8217;s prior consent, prepare, use or refer to, any free writing prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company has been duly incorporated, is validly existing as a corporation in good standing under the laws of the State
of Delaware, has the corporate power and authority to own or lease its property and to conduct its business as described in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus and is duly qualified to transact business
and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in good standing would not, singly
or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Each subsidiary of the Company has been duly incorporated, organized or formed, as applicable, is validly existing as a
corporation or other business entity, as applicable, in good standing under the laws of the jurisdiction of its incorporation, organization or formation, has the corporate or other business entity power and authority, as applicable, to own or lease
its property and to conduct its business as described in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus and is duly qualified to transact business and is in good standing (to the extent the concept of good
standing is applicable in the relevant jurisdiction) in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or be in
good standing would not, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole; all of the issued shares of capital stock or other equity interests of each
subsidiary of the Company have been duly and validly authorized and issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and are owned directly or indirectly by the Company free and clear of all liens, encumbrances,
equities or claims. The subsidiaries listed in Exhibit 21.1 of the Company&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2025 are the only significant subsidiaries (as defined in Rule
<FONT STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act) of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) This Agreement has been duly authorized, executed and delivered by the Company, and the Share Repurchase has been duly
authorized by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The authorized capital stock of the Company conforms as to legal matters to the description
thereof contained in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) The shares of
Common Stock (including the Shares to be sold by the Selling Stockholders) outstanding as of the date hereof have been duly authorized and are validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The execution and delivery by the Company of, and the performance by the Company of its obligations under, this Agreement
(including the Share Repurchase) will not contravene (i)&nbsp;any provision of applicable law, (ii)&nbsp;the certificate of incorporation, <FONT STYLE="white-space:nowrap">by-laws</FONT> or other organizational documents of the Company or any of its
subsidiaries; (iii)&nbsp;any agreement or other instrument binding upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries, taken as a whole; or (iv)&nbsp;any judgment, order or decree of any governmental
body, agency or court having jurisdiction over the Company or any of its subsidiaries, and no consent, approval, authorization or order of, or qualification with, any governmental body, agency or court is required for the performance by the Company
of its obligations under this Agreement (including the Share Repurchase), except such as have been previously obtained or may be required by the securities or Blue Sky laws of the various states or the rules and regulations of the Financial Industry
Regulation Authority, Inc. (&#8220;<B>FINRA</B>&#8221;) in connection with the offer and sale of the Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) There has not occurred any material adverse change, or any development
involving a prospective material adverse change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) The Company is not (i)&nbsp;in violation of its certificate of incorporation or bylaws; (ii)&nbsp;in default, and no event
has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement
or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject; or (iii)&nbsp;in
violation of any law or statute or any judgment order, rule or regulation or any court or arbitrator or governmental or regulatory authority, except, in the case of clause (ii)&nbsp;above, for any such default or violation that would not, singly or
in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) There are no
legal or governmental proceedings pending or, to the Company&#8217;s knowledge, threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject
(i)&nbsp;other than proceedings accurately described in all material respects in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus and proceedings that would not, singly or in the aggregate, reasonably be expected to
have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the power or ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by each of the
Registration Statement, the Time of Sale Prospectus and the Prospectus or (ii)&nbsp;that are required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus and are not so described; and there are no statutes,
regulations, contracts or other documents to which the Company or any of its subsidiaries or assets are subject or bound that are required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus or to be filed as
exhibits to the Registration Statement that are not described in all material respects or filed as required. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Each
preliminary prospectus filed as part of the Registration Statement as originally filed or as part of any amendment thereto, or filed pursuant to Rule&nbsp;424(b) under the Securities Act, complied when so filed in all material respects with the
Securities Act and the applicable rules and regulations of the Commission thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) The Company is not, and after
giving effect to the Share Repurchase, will not be, required to register as an &#8220;investment company&#8221; as such term is defined in the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Neither the Company nor any of its subsidiaries or affiliates has taken, directly or indirectly, any action designed to or
that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) The Company and each of its subsidiaries (i)&nbsp;are in compliance with any and all applicable foreign, federal, state and
local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#8220;<B>Environmental Laws</B>&#8221;), (ii) have received all permits,
licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii)&nbsp;are in compliance with all terms and conditions of any such permit, license or approval, except where such
noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, singly or in the aggregate, reasonably be
expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) There are no costs or liabilities associated with Environmental Laws
(including, without limitation, any capital or operating expenditures required for <FONT STYLE="white-space:nowrap">clean-up,</FONT> closure of properties or compliance with Environmental Laws or any permit, license or approval, any related
constraints on operating activities and any potential liabilities to third parties) that would, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) There are no contracts, agreements or understandings between the Company and any person granting such person the right to
require the Company to file a registration statement under the Securities Act with respect to any securities of the Company or to require the Company to include such securities with the Shares registered pursuant to the Registration Statement except
as have been described in the Time of Sale Prospectus and the Prospectus; and no consent or approval is required from any person granted such rights as described in the Time of Sale Prospectus for the performance by the Company of its obligations
under this Agreement (including the Share Repurchase) and the consummation of the transactions contemplated hereby, except as have been waived prior to the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) (i) None of the Company or any of its subsidiaries or affiliates, or any director, officer or employee thereof, or, to the
Company&#8217;s knowledge, any agent or representative of the Company or of any of its subsidiaries or affiliates, has taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment,
giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any government official (including any officer or employee of a government or government-owned or controlled entity or of a public international
organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office) (&#8220;<B>Government Official</B>&#8221;) in order to influence
official action, or to or from any person in violation of any applicable anti-corruption laws; and (ii)&nbsp;the Company and its subsidiaries and affiliates have conducted their businesses in compliance with applicable anti-corruption laws and have
instituted and maintained and will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) The operations of the Company and each of its subsidiaries are and have been conducted at all times in material compliance
with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct
Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and each of its subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#8220;<B>Anti-Money Laundering Laws</B>&#8221;), and no action, suit or proceeding by or before any court or governmental agency, authority or
body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) (i) None of the Company, any of its subsidiaries or any director, officer or, to the Company&#8217;s knowledge, any
employee, agent, affiliate or representative of the Company or any of its subsidiaries, is an individual or entity (&#8220;<B>Person</B>&#8221;) that is, or is owned or controlled by one or more Persons that are: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) the subject of any sanctions administered or enforced by the U.S. Department of the Treasury&#8217;s Office of Foreign
Assets Control, the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury or other relevant sanctions authority (collectively, &#8220;<B>Sanctions</B>&#8221;), nor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) located, organized or resident in a country or territory that is the
subject of Sanctions (including, without limitation, the Crimea region of Ukraine, the <FONT STYLE="white-space:nowrap">non-government</FONT> controlled areas of the Kherson and Zaporizhzhia regions of Ukraine, the
<FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#8217;s Republic the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#8217;s Republic, or any other Covered Region of Ukraine identified pursuant to Executive Order
14065, Cuba, Iran and North Korea). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The Company and its subsidiaries have not knowingly engaged in, are not now
knowingly engaged in and will not engage in any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Subsequent to the respective dates as of which information is given in each of the Registration Statement, the Time of Sale
Prospectus and the Prospectus, (i)&nbsp;the Company and its subsidiaries, taken as a whole, have not incurred any material liability or obligation, direct or contingent, nor entered into any material transaction; (ii)&nbsp;the Company has not
purchased any of its outstanding capital stock, nor declared, paid or otherwise made any dividend or distribution of any kind on its capital stock other than ordinary and customary dividends; and (iii)&nbsp;there has not been any material change in
the capital stock, short-term debt or long-term debt of the Company and its subsidiaries, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) The
Company and each of its subsidiaries have good and marketable title in fee simple to all real property, if any, and good and marketable title to all personal property owned by them which is material to the business of the Company and its
subsidiaries, taken as a whole, in each case free and clear of all liens, encumbrances and defects except such as do not materially diminish the value of such property and do not materially interfere with the use made and proposed to be made of such
property by the Company and its subsidiaries, taken as a whole; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not
material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) (i) The Company and each of its subsidiaries own or have a valid license to all patents, inventions, copyrights, know how
(including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks and trade names (collectively, &#8220;<B>Intellectual Property Rights</B>&#8221;) used in or
reasonably necessary to the conduct of their businesses as now currently conducted by them; (ii)&nbsp;the Intellectual Property Rights owned by the Company and each of its subsidiaries and, to the Company&#8217;s knowledge, the Intellectual Property
Rights licensed to the Company and each of its subsidiaries are valid, subsisting and enforceable, and there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity, scope
or enforceability of any such Intellectual Property Rights; (iii)&nbsp;neither the Company nor any of its subsidiaries has received any notice alleging any infringement, misappropriation or other violation of Intellectual Property Rights;
(iv)&nbsp;to the Company&#8217;s knowledge, no third party is infringing, misappropriating or otherwise violating, or has infringed, misappropriated or otherwise violated, any Intellectual Property Rights owned by the Company; (v)&nbsp;none of the
Company nor any of its subsidiaries infringes, misappropriates or otherwise violates, or has infringed, misappropriated or otherwise violated, any Intellectual Property Rights of any person or entity; (vi)&nbsp;all employees or contractors engaged
in the development of Intellectual Property Rights on behalf of the Company or any of its subsidiaries have executed an invention assignment agreement whereby such employees or contractors presently assign all of their right, title and interest in
and to such Intellectual Property Rights to the Company or the applicable subsidiary, and to the Company&#8217;s knowledge no such agreement has been breached or violated; and (vii)&nbsp;the Company and its subsidiaries use, and have used,
commercially reasonable efforts to appropriately maintain the confidentiality of all information intended to be maintained as a trade secret. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) (i) The Company and its subsidiaries use and have used any and all
software and other materials distributed under a &#8220;free,&#8221; &#8220;open source,&#8221; or similar licensing model (including, but not limited to, the MIT License, Apache License, GNU General Public License, GNU Lesser General Public License
and GNU Affero General Public License) (&#8220;<B>Open Source Software</B>&#8221;) in compliance in all material respects with all license terms applicable to such Open Source Software; and (ii)&nbsp;neither the Company nor any of its subsidiaries
uses or distributes or has used or distributed any Open Source Software in any manner that requires or has required (A)&nbsp;the Company or any of its subsidiaries to permit reverse engineering of any software code or other technology owned by the
Company or any of its subsidiaries or (B)&nbsp;any software code or other technology owned by and material to the Company or any of its subsidiaries to be (1)&nbsp;disclosed or distributed in source code form, (2)&nbsp;licensed for the purpose of
making derivative works or (3)&nbsp;redistributed at no charge. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) Except as disclosed in the Time of Sale Prospectus and
the Prospectus, the Company and its subsidiaries are, and have been, since July&nbsp;10, 2017, in compliance in all material respects with all applicable Health Care Laws. For purposes of this Agreement, &#8220;<B>Health Care Laws</B>&#8221; means
those health care as applicable to either the Company or its subsidiaries, including, (i)&nbsp;all applicable federal, state and local health care fraud and abuse laws, including, without limitation, the Anti-Kickback Statute (42 U.S.C. <FONT
STYLE="white-space:nowrap">Section&nbsp;1320a-7b(b)),</FONT> the Civil False Claims Act (31 U.S.C. Section&nbsp;3729 et seq.), the Program Fraud Civil Remedies Act (31 U.S.C. 3801-3812), the criminal false statements law (42 U.S.C. <FONT
STYLE="white-space:nowrap">Section&nbsp;1320a-7b(a)),</FONT> 18 U.S.C. Sections 286 and 287, the health care fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Section&nbsp;1320d et seq.)
and its implementing regulations, as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. Section&nbsp;17921 et seq.), (collectively, &#8220;<B>HIPAA</B>&#8221;), the Stark Law (42 U.S.C. Section&nbsp;1395nn),
the Civil Monetary Penalties Law (42 U.S.C. <FONT STYLE="white-space:nowrap">Section&nbsp;1320a-7a),</FONT> the Exclusion Laws (42 U.S.C. <FONT STYLE="white-space:nowrap">Section&nbsp;1320a-7);</FONT> (ii) applicable laws governing government funded
or sponsored healthcare programs, including, without limitation, Title XVIII of the Social Security Act, 42 U.S.C. 1395-1395lll (the Medicare statute) and Title XIX of the Social Security Act, 42 U.S.C.
<FONT STYLE="white-space:nowrap">1396-1396w-5</FONT> (the Medicaid statute); (iii) the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010; (iv) licensure, certification,
quality, safety and accreditation requirements under applicable federal, state or local laws or regulatory bodies, including, but not limited to, all laws relating to the practice of telehealth or telemedicine services, the corporate practice of
licensed professions, the supervision of paraprofessionals, and <FONT STYLE="white-space:nowrap">fee-splitting;</FONT> and (vi)&nbsp;all implementing regulations promulgated pursuant to the foregoing. Without limiting the generality of the
foregoing, except as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, to the Company&#8217;s knowledge, neither the Company nor any of its subsidiaries has received written notice of any claim, charge, action,
suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity is in material violation of any
Health Care Laws nor, to the Company&#8217;s knowledge, is any such claim, charge, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened. The Company and its subsidiaries have filed, maintained or
submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Health Care Laws, and all such reports, documents, forms, notices, applications, records, claims,
submissions and supplements or amendments were complete and accurate on the date filed in all material respects (or were corrected or supplemented by a subsequent submission). Neither the Company nor any of its subsidiaries is a party to any
corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority. The Company maintains a compliance program designed to meet, in all
material respects, elements of an effective corporate compliance and ethics program identified in U.S.S.G. &#167; 8B2.1 (&#8220;<B>Compliance Program</B>&#8221;), has conducted its operations in accordance with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such applicable Compliance Program, and there are no outstanding compliance complaints or reports, ongoing internal investigations, or outstanding compliance corrective actions, except in each
case as would not, singly or in the aggregate, reasonably be expected to have a material adverse effect. Additionally, neither the Company nor any of its subsidiaries or any of their employees, officers, directors, managing employees (as such term
is defined in 42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-5(b)),</FONT> or to the Company&#8217;s knowledge, vendors, independent contractors, or agents, has been excluded, suspended or debarred from participation in any U.S. federal
health care program. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) Except as disclosed in the Time of Sale Prospectus and the Prospectus (i)&nbsp;the Company and
each of its subsidiaries are, and for the past five years, have been, in compliance in all material respects with all internal privacy policies, contractual obligations, applicable data privacy laws (including, without limitation HIPAA and state
laws governing the securitization and/or data localization of electronic medical records systems (&#8220;<B>EMRs</B>&#8221;) and electronic health records (&#8220;<B>EHRs</B>&#8221;)), statutes, judgments, orders, rules and regulations of any
federal, state, or local court or arbitrator or other governmental or regulatory authority and any other legal obligations, in each case, relating to the security of IT Systems or the collection, processing, use, transfer, import, export, storage,
protection, disposal and disclosure by the Company or any of its subsidiaries of, any information relating to an identified or identifiable natural person, including personal data and personally identifiable information (each as defined under
applicable data privacy laws) that alone or in combination with other information can reasonably be used to specifically identify a natural person, household or device (collectively &#8220;<B>Data Security Obligations</B>,&#8221; and such data,
&#8220;<B>Data</B>&#8221;); (ii) the Company and each of its subsidiaries has not received any notification of or complaint regarding, and the Company are unaware of any other facts that, individually or in the aggregate, would reasonably indicate, <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with any Data Security Obligation in any material respect; and (iii)&nbsp;there is no action, suit or proceeding by or before any court or governmental agency, authority or body pending or, to the
Company&#8217;s knowledge, threatened, alleging material <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Data Security Obligation. To the knowledge of the Company, there has been no material unauthorized access to Data of the Company
or its subsidiaries, except where such access has been remedied without material cost or liability or the duty to notify any other person. The Company and each of its subsidiaries have made materially accurate and sufficient disclosures to users or
customers required by applicable Data Security Obligations. The Company and each of its subsidiaries have taken all actions reasonably necessary to comply with all applicable state and federal laws and regulations with respect to Data that have been
announced as of the date hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) The Company and its subsidiaries&#8217; respective information technology assets and
equipment, computers, systems, networks, hardware, software, websites, applications, technology, data and databases (including Data and the data and information of their respective customers, employees, suppliers, vendors and any third party data
maintained, processed or stored by or on behalf of the Company and its subsidiaries) used in connection with the operation of the Company&#8217;s and its subsidiaries&#8217; businesses including EMRs and EHRs (&#8220;<B>IT Systems</B>&#8221;) are
adequate for, and operate and perform in all material respects for the conduct of their businesses as now currently conducted by them, and to the knowledge of the Company and its subsidiaries, are free and clear of all Trojan horses, time bombs,
malware and other corruptants. The Company and its subsidiaries have taken commercially reasonable physical, technical and administrative measures to protect the IT Systems and Data used in connection with the operation of the Company&#8217;s and
its subsidiaries&#8217; businesses, in all material respects. Without limiting the foregoing, the Company and its subsidiaries have used commercially reasonable efforts, consistent with similarly situated companies within the industry in which the
Company and its subsidiaries operates, to establish and maintain, and have established, maintained, implemented and complied with, reasonable information technology, information security, cyber security and data protection controls, policies and
procedures, including oversight; access controls; encryption; administrative, technological and physical safeguards and business continuity/disaster recovery and security plans that are designed to protect against and prevent material breach,
destruction, loss, unauthorized distribution, acquisition, use, access, disclosure, disablement, misappropriation or modification, or other compromise or misuse of or relating to any IT System or Data used in connection with the operation of the
Company&#8217;s and its subsidiaries&#8217; businesses (&#8220;<B>Breach</B>&#8221;). To the knowledge of the Company and its subsidiaries there has been no material Breach, and the Company and its subsidiaries have not been notified of, or
identified, any event or condition that would reasonably be expected to result in, any such Breach. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) No material labor dispute with the employees of the Company or any of
its subsidiaries exists, or, to the knowledge of the Company, is imminent; and the Company is not aware of any existing, threatened or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers or contractors that
would reasonably be expected to, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) (i) Each employee benefit plan, within the meaning of Section&nbsp;3(3) of and subject to the requirements of the Employee
Retirement Income Security Act of 1974, as amended (&#8220;<B>ERISA</B>&#8221;), for which the Company or any member of their &#8220;Controlled Group&#8221; (defined as any entity, whether or not incorporated, that is under common control with the
Company, as applicable, within the meaning of Section&nbsp;4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company, as applicable, under Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Internal Revenue Code
of 1986, as amended (the &#8220;<B>Code</B>&#8221;)) would have any liability (each, a &#8220;<B>Plan</B>&#8221;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations,
including but not limited to ERISA and the Code; (ii)&nbsp;no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any Plan, excluding transactions effected pursuant
to a statutory or administrative exemption; (iii)&nbsp;for each Plan that is subject to the funding rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, no Plan has failed (whether or not waived), or is reasonably expected to fail, to
satisfy the minimum funding standards (within the meaning of Section&nbsp;302 of ERISA or Section&nbsp;412 of the Code) applicable to such Plan; (iv)&nbsp;no Plan is, or is reasonably expected to be, in &#8220;at risk status&#8221; (within the
meaning of Section&nbsp;303(i) of ERISA) and no Plan that is a &#8220;multiemployer plan&#8221; within the meaning of Section&nbsp;4001(a)(3) of ERISA is in &#8220;endangered status&#8221; or &#8220;critical status&#8221; (within the meaning of
Sections 304 and 305 of ERISA); (v) no &#8220;reportable event&#8221; (within the meaning of Section&nbsp;4043(c) of ERISA and the regulations promulgated thereunder) has occurred or is reasonably expected to occur; (vi)&nbsp;each Plan that is
intended to be qualified under Section&nbsp;401(a) of the Code is the subject of a favorable determination letter from the Internal Revenue Service (&#8220;<B>IRS</B>&#8221;) or is able to rely on a favorable opinion or advisory letter from the IRS
regarding its <FONT STYLE="white-space:nowrap">tax-qualified</FONT> status, and nothing has occurred, whether by action or by failure to act, which would be reasonably expected to cause such letter to be revoked; (vii)&nbsp;neither of the Company
nor any member of the Controlled Group has in the last six years incurred, nor reasonably expects to incur, any liability under Title IV of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guarantee Corporation, in the
ordinary course and without default) in respect of a Plan (including a &#8220;multiemployer plan&#8221; within the meaning of Section&nbsp;4001(a)(3) of ERISA); and (viii)&nbsp;no material increase in the Company and its subsidiaries&#8217;
&#8220;accumulated post-retirement benefit obligations&#8221; (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations in the Company and its subsidiaries&#8217; most recently completed fiscal
year has occurred in the most recently completed fiscal year, except in each case with respect to the events or conditions set forth in (i)&nbsp;through (viii) hereof, as would not, singly or in the aggregate, reasonably be expected to have a
material adverse effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) The Company and each of its subsidiaries are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are, in the Company&#8217;s reasonable judgment, prudent and customary in the businesses in which they are engaged; none of the Company or any of its subsidiaries has been refused
any insurance coverage sought or applied for, except as would not reasonably be expected to have a material adverse effect on the Company and each of its subsidiaries, taken as a whole; and none of the Company or any of its subsidiaries has any
reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not, singly
or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) The Company and its subsidiaries possess all certificates, licenses,
enrollments, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct their respective businesses, and none of the Company or any of its subsidiaries has received any notice of
proceedings relating to the revocation, cancellation, termination or material adverse modification of any such certificate, license, enrollment, authorization or permit which, singly or in the aggregate, if the subject of an unfavorable decision,
ruling or finding, would reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) The financial statements incorporated by reference in each of the Registration Statement, the Time of Sale Prospectus and
the Prospectus, together with the related schedules and notes thereto, comply as to form in all material respects with the applicable accounting requirements of the Securities Act and present fairly the consolidated financial position of the Company
and its subsidiaries as of the dates shown and its results of operations and cash flows for the periods shown, and such financial statements have been prepared in conformity with generally accepted accounting principles in the United States
(&#8220;<B>U.S. GAAP</B>&#8221;) applied on a consistent basis throughout the periods covered thereby except for any normal <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments in the Company&#8217;s quarterly financial statements. The other
financial information included, or incorporated by reference, in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and
presents fairly in all material respects the information shown thereby. All disclosures included or incorporated by reference in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus regarding <FONT
STYLE="white-space:nowrap">&#8220;non-GAAP</FONT> financial measures&#8221; (as such term is defined by the rules and regulations of the Commission) comply with Regulation G of the Exchange Act and Item 10 of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> of the Securities Act, to the extent applicable. The statistical, industry-related and market-related data included, or incorporated by reference, in each of the Registration Statement, the Time of Sale
Prospectus and the Prospectus are based on or derived from sources which the Company reasonably and in good faith believes are reliable and accurate and such data is consistent with the sources from which they are derived, in each case in all
material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) PricewaterhouseCoopers LLP, who have certified certain financial statements of the Company and its
subsidiaries and delivered its report with respect to the audited consolidated financial statements and schedules filed with the Commission incorporated by reference in each of the Registration Statement, the Time of Sale Prospectus and the
Prospectus, is an independent registered public accounting firm with respect to the Company within the meaning of the Securities Act and the applicable rules and regulations thereunder adopted by the Commission and the Public Company Accounting
Oversight Board (United States). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Except as described in the Registration Statement, the Time of Sale Prospectus and
the Prospectus, the Company and its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#8217;s general or specific
authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with
management&#8217;s general or specific authorization; (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v)&nbsp;the
interactive data in eXtensible Business Reporting Language included in or incorporated by reference in the Registration Statement is accurate and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. Except
as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, since the end of the Company&#8217;s most recent audited fiscal year, there has been (i)&nbsp;no material weakness in the Company&#8217;s internal control
over financial reporting (whether or not remediated), and (ii)&nbsp;no change in the Company&#8217;s internal control over financial reporting that has materially and adversely affected, or is reasonably likely to materially and adversely affect,
the Company&#8217;s internal control over financial reporting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) Except as described in the Registration Statement, the Time of Sale
Prospectus and the Prospectus, the Company has not sold, issued or distributed any shares of Common Stock during the <FONT STYLE="white-space:nowrap">six-month</FONT> period preceding the date hereof, including any sales pursuant to Rule&nbsp;144A
under, or Regulation&nbsp;D or S of, the Securities Act, other than shares issued pursuant to employee benefit plans, qualified stock option plans or other employee compensation plans or pursuant to outstanding options, rights or warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) The Company and its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed through
the date of this Agreement or have requested extensions thereof (except where the failure to file would not, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole) and have paid all taxes
required to be paid thereon (except for cases in which the failure to file or pay would not, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole, or, except as
currently being contested in good faith and for which reserves required by U.S. GAAP have been created in the financial statements of the Company), and no tax deficiency has been determined adversely to the Company or any of its subsidiaries which,
singly or in the aggregate, remains unpaid and has had (nor does the Company or any of its subsidiaries have any notice or knowledge of any tax deficiency which remains unpaid and would reasonably be expected to be determined adversely to the
Company or its subsidiaries and which would have) a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) The Company (i)&nbsp;has not alone engaged in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication with any person or entity and (ii)&nbsp;has not authorized anyone to engage in <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company has not distributed any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that is a written
communication as defined in Rule 405 under the Securities Act. &#8220;<B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication</B>&#8221; means any communication with potential investors
undertaken in reliance on Section&nbsp;5(d) or Rule 163B of the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) As of the time of each sale of the
Shares in connection with the offering when the Prospectus is not yet available to prospective purchasers, none of (A)&nbsp;the Time of Sale Prospectus, (B)&nbsp;any free writing prospectus, when considered together with the Time of Sale Prospectus,
and (C)&nbsp;any individual <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, when considered together with the Time of Sale Prospectus, included, includes or will include an untrue
statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that this
representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with the Underwriter Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn) The statements in the Time of Sale Prospectus and the Prospectus under the headings &#8220;Material U.S. Federal Income
Tax Considerations to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders&#8221; and &#8220;Underwriting&#8221; insofar as such statements summarize legal matters, agreements, documents or proceedings are accurate and fair summaries of such
legal matters, agreements, documents or proceedings. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) No relationships, direct or indirect, exist between or among the
Company or any of its subsidiaries, on the one hand, and the directors, officers, equityholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required by the Securities Act to be described
in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Time of Sale Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) There is and has been no failure on the part of the Company or any of
the Company&#8217;s directors or officers, in their capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection therewith, including
Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications, to the extent compliance is required as of the date of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) The Company and each of its subsidiaries maintain an effective system of &#8220;disclosure controls and procedures&#8221;
(as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> under the Exchange Act) that has been designed to comply with the requirements of the Exchange Act and has been designed to ensure that information required to be disclosed by the
Company in reports that it files or&nbsp;submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&#8217;s rules and forms, including controls and procedures designed to ensure
that such information is accumulated and communicated to the Company&#8217;s principal executive officer and principal financial officer as appropriate to allow timely decisions regarding required disclosure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) No forward-looking statement (within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the
Exchange Act) included or incorporated by reference in any of the Registration Statement, the Time of Sale Prospectus or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <I>Representations and Warranties of the Selling Stockholders</I>. Each Selling Stockholder, severally and not jointly, represents and
warrants to and agrees with the Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) This Agreement has been duly authorized, executed and delivered by
or on behalf of such Selling Stockholder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The execution and delivery by such Selling Stockholder of, and the
performance by such Selling Stockholder of its obligations under, this Agreement will not contravene (i)&nbsp;any provision of applicable law, (ii)&nbsp;the organizational and/or formation documents of such Selling Stockholder (if such Selling
Stockholder is not a natural person), (iii) any agreement or other instrument binding upon such Selling Stockholder or (iv)&nbsp;any judgment, order or decree of any governmental body, agency or court having jurisdiction over such Selling
Stockholder, except in the case of clauses (i), (iii) and (iv)&nbsp;as would not, singly or in the aggregate, have a material adverse effect on the ability of such Selling Stockholder to consummate the transactions contemplated by this Agreement and
no consent, approval, authorization or order of, or qualification with, any governmental body, agency or court is required for the performance by such Selling Stockholder of its obligations under this Agreement, except (a)&nbsp;such as may be
required by the securities or Blue Sky laws of the various states or foreign jurisdictions or the rules and regulations of FINRA in connection with the offer and sale of the Shares or (b)&nbsp;such as would not reasonably be expected to have a
material adverse effect on the ability of such Selling Stockholder to consummate the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Such Selling Stockholder has, and on the Closing Date will have, valid title to, or a valid &#8220;security
entitlement&#8221; (as defined in <FONT STYLE="white-space:nowrap">Section&nbsp;8-102</FONT> of the New York Uniform Commercial Code) in respect of, the Shares to be sold by such Selling Stockholder free and clear of all security interests, claims,
liens, equities or other encumbrances and the legal right and power, and all authorization and approval required by law, to enter into this Agreement and to sell, transfer and deliver the Shares to be sold by such Selling Stockholder or a security
entitlement in respect of such Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Selling Stockholder formed in a jurisdiction outside of the United States
(the &#8220;<B><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder</B>&#8221;) represents that no stamp, documentary, issuance, registration, transfer, withholding, capital gains, income or other taxes or duties are payable by or on
behalf of the Underwriter, the Company or any of its subsidiaries in the Cayman Islands or to any taxing authority thereof or therein in connection with (i)&nbsp;the execution, delivery or consummation of this Agreement, (ii)&nbsp;the sale and
delivery of the Shares to the Underwriter or purchasers procured by the Underwriter, or (iii)&nbsp;the resale and delivery of the Shares by the Underwriter in the manner contemplated herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling
Stockholder has the power to submit, and pursuant to Section&nbsp;18(a) has, to the extent permitted by law, legally, validly, effectively and irrevocably submitted, to the jurisdiction of the Specified Courts (as defined in Section&nbsp;18(a)), and
has the power to designate, appoint and empower, and pursuant to Section&nbsp;18(b), has legally, validly and effectively designated, appointed and empowered an agent for service of process in any suit or proceeding based on or arising under this
Agreement in any of the Specified Courts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Upon payment for the Shares to be sold by such Selling Stockholder pursuant
to this Agreement, delivery of such Shares, as directed by the Underwriter, to Cede&nbsp;&amp; Co. (&#8220;<B>Cede</B>&#8221;) or such other nominee as may be designated by The Depository Trust Company (&#8220;<B>DTC</B>&#8221;), registration of
such Shares in the name of Cede or such other nominee and the crediting of such Shares on the books of DTC to securities accounts of the Underwriter (assuming that neither DTC nor the Underwriter has notice of any adverse claim (within the meaning
of <FONT STYLE="white-space:nowrap">Section&nbsp;8-105</FONT> of the New York Uniform Commercial Code (the &#8220;<B>UCC</B>&#8221;)) to such Shares), (A)&nbsp;DTC shall be a &#8220;protected purchaser&#8221; of such Shares within the meaning of <FONT
STYLE="white-space:nowrap">Section&nbsp;8-303</FONT> of the UCC, (B)&nbsp;under <FONT STYLE="white-space:nowrap">Section&nbsp;8-501</FONT> of the UCC, the Underwriter will acquire a valid security entitlement in respect of such Shares and
(C)&nbsp;no action based on any &#8220;adverse claim,&#8221; within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;8-102</FONT> of the UCC, to such Shares may be asserted against the Underwriter with respect to such security
entitlement; for purposes of this representation, such Selling Stockholder may assume that when such payment, delivery and crediting occur, (x)&nbsp;such Shares will have been registered in the name of Cede or another nominee designated by DTC, in
each case on the Company&#8217;s share registry in accordance with its certificate of incorporation, bylaws and applicable law, (y)&nbsp;DTC will be registered as a &#8220;clearing corporation&#8221; within the meaning of <FONT
STYLE="white-space:nowrap">Section&nbsp;8-102</FONT> of the UCC and (z)&nbsp;appropriate entries to the accounts of the Underwriter on the records of DTC will have been made pursuant to the UCC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Such Selling Stockholder has delivered to the Underwriter an executed <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreement in substantially the form attached hereto as Exhibit A (the &#8220;<B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement</B>&#8221;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) (i) The Registration Statement, when it became effective, did not contain and, as amended or supplemented, if applicable,
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (ii)&nbsp;the Time of Sale Prospectus does not, and at the time of
each sale of the Shares in connection with the offering when the Prospectus is not yet available to prospective purchasers and at the Closing Date (as defined in Section&nbsp;5), the Time of Sale Prospectus, as then amended or supplemented by the
Company, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading,
(iii)&nbsp;each broadly available road show, if any, when considered together with the Time of Sale Prospectus, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading and (iv)&nbsp;the Prospectus does not contain and, as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, provided that the representations and warranties set forth in this paragraph&nbsp;are limited in all respects to
statements or omissions in the Registration Statement, the Time of Sale Prospectus or the Prospectus made in reliance upon and in conformity with information relating to such Selling Stockholder furnished to the Company in writing by such Selling
Stockholder expressly for use in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any issuer free writing prospectus, road show, or the Prospectus or any amendment or supplement thereto, it being understood and
agreed that the only information furnished by such Selling Stockholder consists of the name of such Selling Stockholder, the number of shares offered by such Selling Stockholder and the address and other information with respect to such Selling
Stockholder (excluding percentages) that appear in the Registration Statement or any Prospectus in the table (and corresponding footnotes) under the caption &#8220;Selling Stockholders&#8221; (with respect to each Selling Stockholder, the
&#8220;<B>Selling Stockholder Information</B>&#8221;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <I>Agreements to Sell and Purchase</I>. Each Selling Stockholder, severally and not
jointly, hereby agrees to sell to the Underwriter, upon the basis of the representations and warranties herein contained, but subject to the terms and conditions hereinafter stated, agrees, severally and not jointly, to purchase from such Selling
Stockholder at $7.01 a share (the &#8220;<B>Purchase Price</B>&#8221;) the number of Shares set forth in Schedule&nbsp;I hereto opposite the name of the Underwriter. Subject to the sale of the Shares by the Selling Stockholders to the Underwriter in
compliance with the terms of this Agreement, the Underwriter agrees to sell to the Company, and the Company agrees to purchase from the Underwriter, the number of Repurchase Shares set forth in Schedule II hereto opposite the name of such Selling
Stockholder at the Purchase Price. The Company represents that it is acquiring the Repurchase Shares for investment purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <I>Terms
of Public Offering</I>. The Selling Stockholders are advised by the Underwriter that the Underwriter proposes to make a public offering of their respective portions of the Shares as soon after the Registration Statement and this Agreement have
become effective as in the Underwriter&#8217;s judgment is advisable. The Company and the Selling Stockholders are further advised by the Underwriter that the Shares are to be offered to the public upon the terms set forth in the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <I>Payment and Delivery</I>. Payment for the Shares to be sold by each Selling Stockholder shall be made to such Selling Stockholder in
Federal or other funds immediately available in New York City against delivery of such Shares for the respective accounts of the Underwriter at 10:00&nbsp;a.m., New York City time, on March&nbsp;2, 2026, or at such other time on the same or such
other date, not later than March&nbsp;6, 2026,<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>as shall be designated in writing by the Underwriter. The time and date of such payment are hereinafter referred to as the &#8220;<B>Closing
Date</B>.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the sale of the Shares to the Underwriter in compliance with the terms of this Agreement, payment for the
Repurchase Shares shall be made by the Company to the Underwriter in Federal or other funds immediately available in New York City against delivery of such Repurchase Shares for the account of the Company at the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Shares shall be registered in such names and in such denominations as the Underwriter shall request not later than one full business day
prior to the Closing Date. The Shares shall be delivered to the Underwriter on the Closing Date for the respective accounts of the Underwriter against payment of the Purchase Price therefor and with any transfer, stamp or other similar taxes payable
in connection with the transfer of the Shares to the Underwriter duly paid as set forth in Section&nbsp;8(c) and Section&nbsp;8(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.
<I>Conditions to the Underwriter</I><I>&#8217;</I><I>s</I><I> Obligations</I>. The several obligations of the Underwriter are subject to the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subsequent to the execution and delivery of this Agreement and prior to the Closing Date: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the respective representations and warranties of the Company and the Selling Stockholders contained herein shall be true
and correct on the date hereof and on and as of the Closing Date; the statements of the Company, the Selling Stockholders and their respective officers, as applicable, made in any certificates delivered pursuant to this Agreement shall be true and
correct on and as of the Closing Date; and the Company and the Selling Stockholders shall have complied with all of the agreements and satisfied all of the conditions on their part to be performed or satisfied hereunder on or before the Closing
Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) no order suspending the effectiveness of the Registration Statement
shall be in effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential
downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any of the securities of the Company or any of its subsidiaries by any &#8220;nationally recognized statistical
rating organization,&#8221; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) there shall not
have occurred any change, or any development involving a prospective change, in the condition, financial or otherwise, or in the earnings, business, or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time
of Sale Prospectus that, in the Underwriter&#8217;s judgment, is material and adverse and that makes it, in the Underwriter&#8217;s judgment, impracticable to market the Shares on the terms and in the manner contemplated in the Time of Sale
Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Underwriter shall have received on the Closing Date certificates, dated the Closing Date and signed by
an executive officer of each of the Company and each Selling Stockholder, to the effect set forth in Sections 6(a)(i) &#8211; (iii) (with respect to the Company) and Section&nbsp;6(a)(i) (with respect to each Selling Stockholder), above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The officer signing and delivering such certificate may rely upon the best of his or her knowledge as to proceedings threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Underwriter shall have received on the Closing Date an opinion and negative assurance letter of Ropes&nbsp;&amp; Gray
LLP, outside counsel for the Company, in form and substance reasonably satisfactory to the Underwriter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The
Underwriter shall have received on the Closing Date an opinion of Ropes&nbsp;&amp; Gray LLP, outside counsel for the Selling Stockholders organized within the United States, in form and substance reasonably satisfactory to the Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Underwriter shall have received on the Closing Date an opinion of Maples and Calder (Cayman) LLP, as Cayman Islands
legal counsel for the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder, in form and substance reasonably satisfactory to the Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The Underwriter shall have received on the Closing Date an opinion and negative assurance letter of Kirkland&nbsp;&amp;
Ellis LLP, counsel for the Underwriter, in form and substance satisfactory to the Underwriter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The Underwriter shall
have received, on each of the date hereof and the Closing Date, a letter dated the date hereof or the Closing Date, as the case may be, in form and substance satisfactory to the Underwriter, from PricewaterhouseCoopers LLP, independent public
accountants, containing statements and information of the type ordinarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained in the
Registration Statement, the Time of Sale Prospectus and the Prospectus; <I>provided</I> that the letter delivered on the Closing Date shall use a <FONT STYLE="white-space:nowrap">&#8220;cut-off</FONT> date&#8221; not earlier than the date hereof.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) The Underwriter shall have received, on each of the date hereof and the Closing Date, a certificate of the principal
financial officer of the Company in form and substance satisfactory to the Underwriter, containing statements and information with respect to certain information contained in the Time of Sale Prospectus and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Underwriter shall have received, on and as of the Closing Date,
satisfactory evidence of the good standing of the Company and each of the subsidiaries set forth on Schedule IV hereto in their respective jurisdictions of organization, in each case in writing or any standard form of telecommunication from the
appropriate governmental authorities of such jurisdictions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) The <FONT STYLE="white-space:nowrap">Lock-up</FONT>
Agreements, each substantially in the form of Exhibit A hereto, between the Underwriter and certain equityholders, officers and directors of the Company shall be in full force and effect on the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the negative assurance letters to be delivered pursuant to Section&nbsp;6, Ropes and Gray LLP and
Kirkland&nbsp;&amp; Ellis LLP may state that their opinions and beliefs are based upon their participation in the preparation of the Registration Statement, the Time of Sale Prospectus and the Prospectus and any amendments or supplements thereto and
review and discussion of the contents thereof, but are without independent check or verification, except as specified. Ropes and Gray LLP and Kirkland&nbsp;&amp; Ellis LLP may rely on the representations and warranties of the parties hereto
contained in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinions of Ropes and Gray LLP described in Section&nbsp;6 above shall be rendered to the
Underwriter at the request of the Company or the Selling Stockholders, as the case may be, and shall so state therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <I>Covenants of
the Company</I>. The Company covenants with each Underwriter as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) To furnish to the Underwriter, a conformed
copy of the Registration Statement as originally filed and each amendment thereto (without exhibits thereto but including documents incorporated by reference) and to furnish to the Underwriter without charge, prior to 10:00&nbsp;a.m. New York City
time on the business day next succeeding the date of this Agreement and during the period mentioned in Section&nbsp;7(e) or 7(f) below, as many copies of the Time of Sale Prospectus, the Prospectus, any documents incorporated by reference therein
and any supplements and amendments thereto or to the Registration Statement as the Underwriter may reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
Before amending or supplementing the Registration Statement, the Time of Sale Prospectus or the Prospectus, to furnish to the Underwriter a copy of each such proposed amendment or supplement and not to file any such proposed amendment or supplement
to which the Underwriter reasonably objects, and to file with the Commission within the applicable period specified in Rule&nbsp;424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To furnish to the Underwriter a copy of each proposed free writing prospectus to be prepared by or on behalf of, used by,
or referred to by the Company and not to use or refer to any proposed free writing prospectus to which the Underwriter reasonably objects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Not to take any action that would result in an Underwriter or the Company being required to file with the Commission
pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriter that the Underwriter otherwise would not have been required to file thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Not to take, or permit any of its subsidiaries or affiliates to take, directly or indirectly, any action designed to or
that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) If the Time of Sale Prospectus is being used to solicit offers to buy
the Shares at a time when the Prospectus is not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Prospectus in order to make the
statements therein, in the light of the circumstances, not misleading, or if any event shall occur or condition exist as a result of which the Time of Sale Prospectus conflicts with the information contained in the Registration Statement then on
file, or if, in the opinion of counsel for the Underwriter, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the
Underwriter and to any dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as so amended or supplemented will not, in the light of the circumstances when the Time
of Sale Prospectus is delivered to a prospective purchaser, be misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the Registration Statement, or so that the Time of Sale Prospectus, as amended
or supplemented, will comply with applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) If, during such period after the first date of the public offering
of the Shares as in the opinion of counsel for the Underwriter the Prospectus (or in lieu thereof the notice referred to in Rule 173(a) of the Securities Act) is required by law to be delivered in connection with sales by an Underwriter or dealer,
any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein, in the light of the circumstances when the Prospectus (or in lieu thereof the notice
referred to in Rule 173(a) of the Securities Act) is delivered to a purchaser, not misleading, or if, in the opinion of counsel for the Underwriter, it is necessary to amend or supplement the Prospectus to comply with applicable law, forthwith to
prepare, file with the Commission and furnish, at its own expense, to the Underwriter and to the dealers (whose names and addresses the Underwriter will furnish to the Company) to which Shares may have been sold by the Underwriter on behalf of the
Underwriter and to any other dealers upon request, either amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances when the Prospectus (or in lieu
thereof the notice referred to in Rule 173(a) of the Securities Act) is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) To endeavor to qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions as the
Underwriter shall reasonably request; provided that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits,
other than those arising out of the offering or sale of the Shares, or taxation in any jurisdiction where it is not now so subject. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To make generally available to the Company&#8217;s security holders and to the Underwriter as soon as practicable an
earnings statement covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement (which may be satisfied by the filing of such statement with the Commission on its
Electronic Data Gathering, Analysis and Retrieval System) which shall satisfy the provisions of Section&nbsp;11(a) of the Securities Act and the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) If any Selling Stockholder is not a U.S. person for U.S. federal income tax purposes, to deliver to each Underwriter (or
its agent), on or before the Closing Date, (i)&nbsp;a certificate with respect to the Company&#8217;s status as a &#8220;United States real property holding corporation,&#8221; dated not more than 30 days prior to the Closing Date, as described in
Treasury Regulations Sections 1.897-2(h) and 1.1445-2(c)(3), and (ii)&nbsp;proof of delivery to the IRS of the required notice, as described in Treasury Regulations 1.897-2(h)(2). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) If at any time following the distribution of any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that is a written communication within the meaning of Rule 405 under the Securities Act there occurred or occurs an event or development as a
result of which such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, to promptly notify the Underwriter and promptly amend or supplement, at its own expense, such <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication to eliminate or correct such untrue statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company also covenants with the Underwriter that, without the prior written consent of the Underwriter, it will not, and will not publicly
disclose an intention to, during the period ending 90 days after the date of the Prospectus (the &#8220;<B>Restricted Period</B>&#8221;), (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or
(2)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause&nbsp;(1) or (2)&nbsp;above is to be
settled by delivery of Common Stock or such other securities, in cash or otherwise or (3)&nbsp;file any registration statement with the Commission relating to the offering of any shares of Common Stock or any securities convertible into or
exercisable or exchangeable for Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions contained in the preceding paragraph shall not apply to (A)&nbsp;the
issuance by the Company of shares of Common Stock upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof as described in each of the Time of Sale Prospectus and Prospectus, (B)&nbsp;facilitating the
establishment of a trading plan on behalf of a stockholder, officer or director of the Company pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of Common Stock, <I>provided</I> that
(i)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted Period and (ii)&nbsp;to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by the Company regarding
the establishment of such plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period, (C)&nbsp;the grant by the Company of awards under equity
incentive plans (including employee stock purchase plans) or other similar arrangements, so long as each plan or arrangement is disclosed in the Time of Sale Prospectus and the Prospectus, (D)&nbsp;the filing of a registration statement on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> (or equivalent form) with the Commission in connection with an employee stock compensation plan or agreement of the Company, which plan or agreement is disclosed in the Time of Sale Prospectus and the Prospectus
and (E)&nbsp;the issuance of shares of Common Stock or other securities (including securities convertible into shares of Common Stock) in connection with the acquisition by the Company or any of its subsidiaries of the securities, businesses, joint
ventures, products or technologies, properties or other assets of another person or entity or pursuant to any equity incentive plan or arrangement, or any employee benefit plan, assumed by the Company in connection with any such transaction (or any
equity incentive plan or arrangement, or any employee benefit plan, to the extent used to issue awards, substitute awards or securities related to any such transaction); provided that the aggregate amount of Securities (on an as converted, as
exercised or as exchanged basis) that the Company may sell or issue or agree to sell or issue pursuant to clause (E)&nbsp;shall not exceed an aggregate of 10% of the total number of shares of Common Stock of the Company issued and outstanding
immediately following the completion of the transactions contemplated by this Agreement determined on a fully diluted basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.
<I>Covenants of the Sell</I><I>ing Stockholders</I> Each Selling Stockholder, severally and not jointly, covenants with each Underwriter as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Selling Stockholder has or will deliver to each Underwriter (or its agent), at or prior to the Closing Date, a
properly completed and executed Internal Revenue Service (&#8220;<B>IRS</B>&#8221;) Form <FONT STYLE="white-space:nowrap">W-9</FONT> or an IRS Form <FONT STYLE="white-space:nowrap">W-8,</FONT> as appropriate, together with all required attachments
to such form. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Selling Stockholder has or will deliver to each Underwriter (or its agent), at or prior to the date
of execution of this Agreement, to the extent such Selling Stockholder is not a natural person, a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together with copies of any additional
documentation necessary to comply with 31 CFR &#167; 1010.230. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) All sums payable by the Company or any Selling Stockholder under this
Agreement shall be paid free and clear of and without deductions or withholdings of any present or future taxes or duties, including any stamp, transfer or other similar taxes, unless the deduction or withholding is required by law, in which case
the Company or the applicable Selling Stockholder, as the case may be, shall pay such additional amount as will result in the receipt by each Underwriter of the full amount that would have been received had no deduction or withholding been made.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) All sums payable to an Underwriter shall be considered exclusive of any stamp, transfer, value added or similar taxes.
Where the Company or, as the case may be, a Selling Stockholder is obliged to pay value added or similar tax on any amount payable hereunder to an Underwriter, the Company or the applicable Selling Stockholder, as the case may be, shall in addition
to the sum payable hereunder pay an amount equal to any applicable stamp, transfer, value added or similar tax. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If any
Selling Stockholder is not a U.S. person for U.S. federal income tax purposes, the Company will deliver to each Underwriter (or its agent) on or before the Closing Date, (i)&nbsp;a certificate with respect to the Company&#8217;s status as a
&#8220;United States real property holding corporation,&#8221; dated not more than thirty (30)&nbsp;days prior to the Closing Date, as described in Treasury Regulations Sections <FONT STYLE="white-space:nowrap">1.897-2(h)</FONT> and <FONT
STYLE="white-space:nowrap">1.1445-2(c)(3),</FONT> and (ii)&nbsp;proof of delivery to the IRS of the required notice, as described in Treasury Regulations <FONT STYLE="white-space:nowrap">1.897-2(h)(2).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <I>Expenses</I>. Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, the
Company agrees to pay or cause to be paid all expenses incident to the performance of their obligations under this Agreement, including: (i)&nbsp;the fees, disbursements and expenses of the Company&#8217;s counsel and accountants and counsel for the
Selling Stockholders in connection with the registration and delivery of the Shares under the Securities Act and all other fees or expenses in connection with the preparation and filing of the Registration Statement, any preliminary prospectus, the
Time of Sale Prospectus, the Prospectus, any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company and amendments and supplements to any of the foregoing, including all printing costs associated therewith, and
the mailing and delivering of copies thereof to the Underwriter and dealers, in the quantities hereinabove specified, (ii)&nbsp;all costs and expenses related to the transfer and delivery of the Shares to the Underwriter, including any transfer,
stamp or other taxes payable thereon, (iii)&nbsp;the cost of printing or producing any Blue Sky or Legal Investment memorandum in connection with the offer and sale of the Shares under state securities laws and all expenses in connection with the
qualification of the Shares for offer and sale under state securities laws as provided in Section&nbsp;7(g) hereof, including filing fees and the reasonable and documented fees and disbursements of counsel for the Underwriter in connection with such
qualification and in connection with the Blue Sky or Legal Investment memorandum, (iv)&nbsp;all filing fees and the reasonable and documented fees and disbursements of counsel to the Underwriter incurred in connection with the review and
qualification of the offering of the Shares by the Financial Industry Regulatory Authority (provided that the aggregate amount payable by the Company with respect to fees and disbursements of counsel to the Underwriter pursuant to clauses
(iii)&nbsp;and (iv) of this Section&nbsp;9 shall not exceed $15,000), (v) the costs and charges of any transfer agent, registrar or depositary, (vi)&nbsp;the costs and expenses of the Company relating to investor presentations on any &#8220;road
show&#8221; undertaken in connection with the marketing of the offering of the Shares, including, without limitation, expenses associated with the preparation or dissemination of any electronic road show, expenses associated with the production of
road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company, travel and lodging expenses of the representatives and officers of the Company and any
such consultants, and 50% of the cost of any aircraft chartered in connection with the road show, (vii)&nbsp;the document production charges and expenses associated with printing this Agreement, and (viii)&nbsp;all other costs and expenses incident
to the performance of the obligations of the Company hereunder for which provision is not otherwise made in this Section. It is understood, however, that except as provided in Section&nbsp;11 and the last paragraph of Section&nbsp;14 below, the
Underwriter will pay all of their costs and expenses, including fees and disbursements of their counsel, stock transfer taxes payable on resale of any of the Shares by them and any advertising expenses connected with any offers they may make, and
50% of the cost of any aircraft chartered in connection with the roadshow. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of this Section shall not supersede or otherwise affect any agreement that
the Company and the Selling Stockholders may otherwise have for the allocation of such expenses among themselves. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <I>Covenants of the
</I><I>Underwriter</I>. The Underwriter covenants with the Company not to take any action that would result in the Company being required to file with the Commission under Rule 433(d) a free writing prospectus prepared by or on behalf of the
Underwriter that otherwise would not be required to be filed by the Company, thereunder, but for the action of the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.
<I>Indemnity and Contribution</I>. (a)&nbsp;The Company, jointly and severally, agree to indemnify and hold harmless each Underwriter, its directors, officers, employees and agents, each person, if any, who controls the Underwriter within the
meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and each affiliate of the Underwriter within the meaning of Rule&nbsp;405 under the Securities Act from and against any and all losses, claims, damages
and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) that arise out of, or are based upon, any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any amendment or supplement thereto, any issuer free writing prospectus as defined in Rule
433(h) under the Securities Act, any Company information filed, or required to be filed, pursuant to Rule 433(d) under the Securities Act, any &#8220;road show&#8221; as defined in Rule 433(h) under the Securities Act (a &#8220;<B>road
show</B>&#8221;), the Prospectus or any amendment or supplement thereto, or any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or arise out of, or are based upon, any omission or
alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any such
untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information (i)&nbsp;relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use in the
Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any issuer free writing prospectus, road show, or the Prospectus or any amendment or supplement thereto, it being understood and agreed that the only such information
furnished by the Underwriter consists of the Underwriter Information and (ii)&nbsp;relating to any Selling Stockholder furnished to the Company in writing by such Selling Stockholder expressly for use therein, it being understood and agreed that
only such information furnished by such Selling Stockholder consists of the Selling Stockholder Information with respect to such Selling Stockholder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Selling Stockholder agrees, severally and not jointly, to indemnify and hold harmless each Underwriter, its directors,
officers, employers and agents, each person, if any, who controls the Underwriter within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and each affiliate of the Underwriter within the meaning of
Rule 405 under the Securities Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or
claim) that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any
amendment or supplement thereto, any issuer free writing prospectus as defined in Rule 433(h) under the Securities Act, any Company information filed, or required to be filed, pursuant to Rule 433(d) under the Securities Act, any road show, the
Prospectus or any amendment or supplement thereto, or any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or arise out of, or are based upon, any omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein not misleading, (A)&nbsp;except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any such untrue statement or
omission or alleged untrue statement or omission made in reliance upon and in conformity with any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
information relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use in the Registration Statement, any preliminary prospectus, the Time of Sale
Prospectus, any issuer free writing prospectus, road show, or the Prospectus or any amendment or supplement thereto, it being understood and agreed that the only such information furnished by the Underwriter consists of the Underwriter Information,
and (B)&nbsp;only to the extent such losses, claims, damages or liabilities are caused by any untrue statement or omission or alleged untrue statement or omission made in reliance on and in conformity with the Selling Stockholder Information
provided by such Selling Stockholder. The liability of each Selling Stockholder under the indemnity agreement contained in this paragraph shall be limited to an amount equal to the aggregate net proceeds (after underwriting discounts and commissions
but before deducting expenses) received by such Selling Stockholder for the Shares sold by such Selling Stockholder under this Agreement (with respect to each Selling Stockholder, the &#8220;<B>Selling Stockholder Proceeds</B>&#8221;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, the Selling Stockholders,
the directors of the Company, the officers of the Company who sign the Registration Statement and each person, if any, who controls the Company or any Selling Stockholder within the meaning of either Section&nbsp;15 of the Securities Act or
Section&nbsp;20 of the Exchange Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or
claim) that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any
amendment or supplement thereto, any issuer free writing prospectus as defined in Rule 433(h) under the Securities Act, any Company information filed, or required to be filed, pursuant to Rule 433(d) under the Securities Act, any road show or the
Prospectus or any amendment or supplement thereto, or arise out of, or are based upon, any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, but
only with reference to information relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, any issuer free writing
prospectus, road show, or the Prospectus or any amendment or supplement thereto, it being understood and agreed that the only such information furnished by the Underwriter consists of: the fifteenth and seventeenth paragraphs under the caption
&#8220;Underwriting&#8221; in the Prospectus (the &#8220;<B>Underwriter Information</B>&#8221;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) In case any
proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought pursuant to Section&nbsp;11(a), 11(b) or 11(c) such person (the &#8220;<B>indemnified party</B>&#8221;) shall
promptly notify the person against whom such indemnity may be sought (the &#8220;<B>indemnifying party</B>&#8221;) in writing and the indemnifying party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the
indemnified party to represent the indemnified party and any others the indemnifying party may designate in such proceeding and shall pay the reasonable and documented fees and disbursements of such counsel related to such proceeding. In any such
proceeding, any indemnified party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i)&nbsp;the indemnifying party and the indemnified party shall have
mutually agreed to the retention of such counsel or (ii)&nbsp;the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same
counsel would be inappropriate due to actual or potential differing interests between them. It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or
related proceedings in the same jurisdiction, be liable for (i)&nbsp;the fees and expenses of more than one separate firm (in addition to any local counsel) for the Underwriter and all persons, if any, who control the Underwriter within the meaning
of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act or who are affiliates of the Underwriter within the meaning of Rule&nbsp;405 under the Securities Act, (ii)&nbsp;the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
fees and expenses of more than one separate firm (in addition to any local counsel) for the Company, the directors of the Company, the officers of the Company who sign the Registration Statement
and each person, if any, who controls the Company within the meaning of either such Section and (iii)&nbsp;the fees and expenses of more than one separate firm (in addition to any local counsel) for all Selling Stockholders and all persons, if any,
who control any Selling Stockholder within the meaning of either such Section, and that all such fees and expenses shall be reimbursed as they are incurred. In the case of any such separate firm for the Underwriter and such control persons and
affiliates of the Underwriter, such firm shall be designated in writing by the Underwriter. In the case of any such separate firm for the Company and such directors of the Company, officers of the Company who sign the Registration Statement and
control persons of the Company, such firm shall be designated in writing by the Company. In the case of any such separate firm for the Selling Stockholders and such control persons of any Selling Stockholders, such firm shall be designated in
writing by the persons named as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> for the Selling Stockholders under the Powers of Attorney. The indemnifying party shall not be liable for any
settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or
liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as
contemplated by the second and third sentences of this paragraph, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than
30 days after receipt by such indemnifying party of the aforesaid request and (ii)&nbsp;such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying
party shall, without the prior written consent of the indemnified party (which consent shall not be unreasonably withheld), effect any settlement of any pending or threatened proceeding in respect of which any indemnified party is or could have been
a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement (x)&nbsp;includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding
and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) To the extent the indemnification provided for in Section&nbsp;11(a), 11(b) or 11(c) is unavailable to an indemnified party
or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or
payable by such indemnified party as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the indemnifying party or parties on the one hand and the
indemnified party or parties on the other hand from the offering of the Shares or (ii)&nbsp;if the allocation provided by clause&nbsp;11(d)(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause&nbsp;11(d)(i) above but also the relative fault of the indemnifying party or parties on the one hand and of the indemnified party or parties on the other hand in connection with the statements or omissions
that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Selling Stockholders on the one hand and the Underwriter on the other hand in connection with
the offering of the Shares shall be deemed to be in the same respective proportions as the net proceeds from the offering of the Shares (before deducting expenses) received by the Selling Stockholders bear to the difference between the aggregate
Purchase Price and the aggregate price at which the Shares are sold by the Underwriter to the public. The relative fault of the Company and of each Selling Stockholder on the one hand and the Underwriter on the other hand shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Selling Stockholders or by the
Underwriter and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Underwriter&#8217;s obligations to contribute pursuant to this Section&nbsp;11 are several in
proportion to the respective </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
number of Shares they have purchased hereunder, and not joint. The Company and the Selling Stockholder&#8217;s respective obligations to contribute pursuant to this Section&nbsp;11 are several in
proportion to the respective number of Shares they have sold hereunder, and not joint. Notwithstanding the foregoing provisions, the liability of each Selling Stockholder under the contribution agreement contained in this Section&nbsp;11(e) and the
indemnity agreement contained in Section&nbsp;11(b) shall be limited in the aggregate to an amount equal to the Selling Stockholder Proceeds of such Selling Stockholder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The Company, the Selling Stockholders and the Underwriter agree that it would not be just or equitable if contribution
pursuant to this Section&nbsp;11 were determined by <I>pro rata</I> allocation or by any other method of allocation that does not take account of the equitable considerations referred to in Section&nbsp;11(d). The amount paid or payable by an
indemnified party as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;11(d) shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;11, no Underwriter shall be required to contribute any amount in excess of the amount by which the total
price at which the Shares underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages that the Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The remedies provided for in this Section&nbsp;11 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The indemnity and contribution provisions contained in this Section&nbsp;11 and the representations, warranties and other
statements of the Company and the Selling Stockholders contained in this Agreement shall remain operative and in full force and effect regardless of (i)&nbsp;any termination of this Agreement, (ii)&nbsp;any investigation made by or on behalf of the
Underwriter, any person controlling the Underwriter or any affiliate of the Underwriter, by or on behalf of any Selling Stockholder or any person controlling any Selling Stockholder, or by or on behalf of the Company, their respective officers or
directors or any person controlling the Company and (iii)&nbsp;acceptance of and payment for any of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <I>Termination</I>.
The Underwriter may terminate this Agreement by notice given to the Company, if after the execution and delivery of this Agreement and prior to or on the Closing Date, (i)&nbsp;trading generally shall have been suspended or materially limited on, or
by, as the case may be, either of the New York Stock Exchange or the Nasdaq Global Select Market, (ii)&nbsp;trading of any securities of the Company shall have been suspended on any exchange or in any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, (iii)&nbsp;a material disruption in securities settlement, payment or clearance services in the United States shall have occurred, (iv)&nbsp;a general moratorium on commercial banking
activities shall have been declared by Federal or New York State authorities or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, or any change in financial markets or any calamity or crisis that, in the
Underwriter&#8217;s judgment, is material and adverse and which, singly or together with any other event specified in this clause&nbsp;(v), makes it, in the Underwriter&#8217;s judgment, impracticable or inadvisable to proceed with the offer, sale
or delivery of the Shares on the terms and in the manner contemplated in the Time of Sale Prospectus or the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.
<I>Effectiveness</I>. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this
Agreement shall be terminated by the Underwriter because of any failure or refusal on the part of the Company or any Selling Stockholder to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company
or any Selling Stockholder shall be unable to perform its obligations under this Agreement, in each case other than as a result of a termination by the Underwriter pursuant to clauses (i), (iii), (iv) or (v)&nbsp;of Section&nbsp;12 hereto, the
Company and the Selling Stockholders, will reimburse the Underwriter for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (including the fees and disbursements of their counsel) reasonably
incurred and documented by the Underwriter in connection with this Agreement or the offering contemplated hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <I>Entire Agreement</I>. (a)&nbsp;This Agreement represents the entire agreement between
the Company and the Selling Stockholders, on the one hand, and the Underwriter, on the other, with respect to the preparation of any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, the conduct of the offering, and the purchase
and sale of the Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company and each Selling Stockholder acknowledge that in connection with the offering of
the Shares: (i)&nbsp;the Underwriter has acted at arm&#8217;s length, is not an agent of, and owes no fiduciary duties to, the Company or any of the Selling Stockholders or any other person, (ii)&nbsp;the Underwriter owes the Company and each
Selling Stockholder only those duties and obligations set forth in this Agreement, any contemporaneous written agreements and prior written agreements (to the extent not superseded by this Agreement), if any, (iii)&nbsp;the Underwriter may have
interests that differ from those of the Company and each Selling Stockholder, and (iv)&nbsp;none of the activities of the Underwriter in connection with the transactions contemplated herein constitutes a recommendation, investment advice, or
solicitation of any action by the Underwriter with respect to any entity or natural person.&nbsp;The Company and each Selling Stockholder waive to the full extent permitted by applicable law any claims it may have against the Underwriter arising
from an alleged breach of fiduciary duty in connection with the offering of the Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Selling Stockholder
further acknowledges and agrees that, although the Underwriter may provide certain Selling Stockholders with certain Regulation Best Interest and Form CRS disclosures or other related documentation in connection with the offering, the Underwriter is
not making a recommendation to any Selling Stockholder to participate in the offering or sell any Shares at the Purchase Price, and nothing set forth in such disclosures or documentation is intended to suggest that the Underwriter is making such a
recommendation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <I>Recognition of the U.S. Special Resolution Regimes</I>. (a)&nbsp;In the event that the Underwriter is a Covered
Entity and becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from the Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer
would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that the Underwriter is a Covered Entity or a BHC Act Affiliate of the Underwriter and becomes subject to a
proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against the Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes
of this Section a &#8220;<B>BHC Act Affiliate</B>&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). &#8220;<B>Covered Entity</B>&#8221; means any of the
following: (i)&nbsp;a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12
C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#8220;<B>Default Right</B>&#8221; has the meaning assigned to that term in, and shall be
interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#8220;<B>U.S. Special Resolution Regime</B>&#8221; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and
(ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <I>Counterparts; Electronic Signature. </I>This Agreement may be signed in two or more
counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile, electronic mail or
other transmission method as permitted by applicable law, and the parties hereto agree that any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. A party&#8217;s electronic
signature (complying with the New York Electronic Signatures and Records Act (N.Y. State Tech. &#167;&#167; 301-309), as amended from time to time, or other applicable law) of this Agreement shall have the same validity and effect as a signature
affixed by the party&#8217;s hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <I>Applicable Law</I>. This Agreement shall be governed by and construed in accordance with the
internal laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <I>Submission</I><I> to Jurisdiction; Appointment of Agents for Service</I>. (a)&nbsp;The <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder irrevocably submits to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of any New York State or United States Federal court sitting in The City of New York (the
&#8220;<B>Specified Courts</B>&#8221;) over any suit, action or proceeding arising out of or relating to this Agreement, the Time of Sale Prospectus, the Prospectus, the Registration Statement or the offering of the Shares (each, a &#8220;<B>Related
Proceeding</B>&#8221;). The <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter have to the laying of venue of any Related
Proceeding brought in such a court and any claim that any such Related Proceeding brought in such a court has been brought in an inconvenient forum. To the extent that the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder has or
hereafter may acquire any immunity (on the grounds of sovereignty or otherwise) from the jurisdiction of any court or from any legal process with respect to itself or its property, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling
Stockholder irrevocably waives, to the fullest extent permitted by law, such immunity in respect of any such suit, action or proceeding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder hereby irrevocably appoints Corporate Creations Network Inc., with
offices at 99 Hudson Street, 5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor, New York, NY 10013 as its agent for service of process in any Related Proceeding and agrees that service of process in any such Related Proceeding may be
made upon it at the office of such agent. The <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder waives, to the fullest extent permitted by law, any other requirements of or objections to personal jurisdiction with respect thereto.
The <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder represents and warrants that such agent has agreed to act as the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder&#8217;s agent for service of process, and
the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder agrees to take any and all action, including the filing of any and all documents and instruments, that may be necessary to continue such appointment in full force and effect.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <I>Judgment Currency</I>. If for the purposes of obtaining judgment in any court it is necessary to convert a sum due hereunder into
any currency other than United States dollars, the parties hereto agree, to the fullest extent permitted by law, that the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Underwriter could purchase
United States dollars with such other currency in The City of New York on the business day preceding that on which final judgment is given. The obligation of the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder with respect to
any sum due from it to the Underwriter or any person controlling the Underwriter shall, notwithstanding any judgment in a currency other than United States dollars, not be discharged until the first business day following receipt by the Underwriter
or controlling person of any sum in such other currency, and only to the extent that the Underwriter or controlling person may in accordance with normal banking procedures purchase United States dollars with such other currency. If the United States
dollars so purchased are less than the sum originally due to the Underwriter or controlling person hereunder, the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder agrees as a separate obligation and notwithstanding any such
judgment, to indemnify the Underwriter or controlling person against such loss. If the United States dollars so purchased are greater than the sum originally due to the Underwriter or controlling person hereunder, the Underwriter or controlling
person agrees to pay to the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder an amount equal to the excess of the dollars so purchased over the sum originally due to the Underwriter or controlling person hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <I>Taxes. </I>If any sum payable by the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder under this Agreement is
subject to tax in the hands of the Underwriter or taken into account as a receipt in computing the taxable income of the Underwriter (excluding net income taxes on underwriting commissions payable hereunder), the sum payable to the Underwriter under
this Agreement shall be increased to such sum as will ensure that the Underwriter shall be left with the sum it would have had in the absence of such tax. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <I>Headings</I>. The headings of the sections of this Agreement have been inserted for
convenience of reference only and shall not be deemed a part of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <I>Notices. </I>All communications hereunder shall be
in writing and effective only upon receipt and if to the Underwriter shall be delivered, mailed or sent to the Underwriter c/o J.P. Morgan Securities LLC 270 Park Avenue New York, New York 10017; if to the Company shall be delivered, mailed or sent
to 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona 85251, Attention: Ryan Pardo; to the Selling Stockholders shall be delivered, mailed or sent to TPG Global, LLC, 301 Commerce Street, Suite 3300, Fort Worth, TX 76102, Attention: General
Counsel; and Summit Partners, 222 Berkeley Street, 18th Floor, Boston, MA 02116, Attention: Chief Compliance Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature pages
follow] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">LifeStance Health Group, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Ryan Pardo</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Ryan Pardo</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title:&#8194; Chief Legal Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL>
P<SMALL>AGE</SMALL> - U<SMALL>NDERWRITING</SMALL> A<SMALL>GREEMENT</SMALL>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TPG VIII LYNNWOOD HOLDINGS</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AGGREGATION, L.P.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: TPG GenPar VIII, L.P. its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: TPG GenPar VIII Advisors, LLC its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Martin Davidson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Martin Davidson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Accounting Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL>
P<SMALL>AGE</SMALL> - U<SMALL>NDERWRITING</SMALL> A<SMALL>GREEMENT</SMALL>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMIT PARTNERS GROWTH</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>EQUITY FUND <FONT STYLE="white-space:nowrap">IX-A,</FONT> L.P.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Partners GE IX, L.P., its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Partners GE IX, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMIT PARTNERS GROWTH</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>EQUITY FUND <FONT STYLE="white-space:nowrap">IX-B,</FONT> L.P.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Partners GE IX, L.P., its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Partners GE IX, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SUMMIT PARTNERS</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ENTREPRENEUR ADVISORS FUND</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>II, L.P.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Partners Entrepreneur Advisors</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GP II, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Master Company, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Member</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SUMMIT INVESTORS GE IX/VC IV, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Investors Management, LLC, its manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Partners L.P., its manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Master Company, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Member</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL>
P<SMALL>AGE</SMALL> - U<SMALL>NDERWRITING</SMALL> A<SMALL>GREEMENT</SMALL>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SUMMIT INVESTORS GE IX/VC IV (UK),</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>L.P.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Investors Management, LLC, its manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Partners L.P., its manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Summit Master Company, LLC, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Darren Black</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Member</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL>
P<SMALL>AGE</SMALL> - U<SMALL>NDERWRITING</SMALL> A<SMALL>GREEMENT</SMALL>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted as of the date hereof</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. Morgan Securities LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Benjamin Burdett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Name:&#8201;&#8202;Benjamin Burdett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-3.00em; font-size:10pt; font-family:Times New Roman">Title:&#8194;&#8201;&#8202;Head of Healthcare ECM</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[S<SMALL>IGNATURE</SMALL>
P<SMALL>AGE</SMALL> - U<SMALL>NDERWRITING</SMALL> A<SMALL>GREEMENT</SMALL>] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE&nbsp;I </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares&nbsp;To&nbsp;Be<BR>Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE&nbsp;II </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Selling Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares To<BR>Be Sold</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Public<BR>Offering<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Repurchase</B><br><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TPG VIII Lynnwood Holdings Aggregation, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,685,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114,893,244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,791,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Summit Partners Growth Equity Fund <FONT STYLE="white-space:nowrap">IX-A,</FONT> L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,642,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,902,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">739,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Summit Partners Growth Equity Fund <FONT STYLE="white-space:nowrap">IX-B,</FONT> L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,649,809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,187,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">461,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Summit Investors GE IX/VC IV, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">113,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Summit Partners Entrepreneur Advisors Fund II, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Selling Stockholder:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Summit Investors GE IX/VC IV (UK), L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">118,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Time of Sale Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Prospectus dated February 25, 2026 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pricing Information: </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Public Offering Shares: 18,000,000 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Repurchase Shares: 7,000,000 </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Public Offering Price: As to each investor, the price paid by such investor. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Free Writing Prospectuses: None. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">III-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Specified Subsidiaries </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">LifeStance TopCo, L.P. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">LifeStance Ultimate Holdings, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Lynnwood Intermediate Holdings, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">LifeStance Health Holdings, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">LifeStance Health, Inc. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">IV-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT&nbsp;A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">February&nbsp;25, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">270 Park Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned
understands that J.P. Morgan Securities, LLC (the &#8220;Underwriter&#8221;) proposes to enter into an Underwriting Agreement (the &#8220;<B>Underwriting Agreement</B>&#8221;) with LifeStance Health Group, Inc., a Delaware corporation (the
&#8220;<B>Company</B>&#8221;), and certain selling stockholders named therein (the &#8220;<B>Selling Stockholders</B>&#8221;) providing for the public offering (the &#8220;<B>Public Offering</B>&#8221;) by the Underwriter, of shares (the
&#8220;<B>Shares</B>&#8221;) of common stock, par value $0.01 per share, of the Company (the &#8220;<B>Common Stock</B>&#8221;). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Underwriting
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To induce the Underwriter that may participate in the Public Offering to continue its efforts in connection with the Public
Offering, the undersigned hereby agrees that, without the prior written consent of the Underwriter, it will not, will not cause any direct or indirect affiliate to, and will not publicly disclose an intention to, during the period commencing on the
date hereof and ending 90 days after the date of the final prospectus (the &#8220;<B>Restricted Period</B>&#8221;) relating to the Public Offering (the &#8220;<B>Prospectus</B>&#8221;), (1) offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock beneficially owned (as such term is used in
Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the Securities Exchange Act of 1934, as amended (the &#8220;<B>Exchange Act</B>&#8221;)), by the undersigned or any other securities so owned convertible into or exercisable or exchangeable for
Common Stock (such securities, together with the Common Stock, the &#8220;<B>Securities</B>&#8221;) or (2)&nbsp;enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of
any Securities, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of Common Stock or other Securities, in cash or otherwise. Without limiting any exclusion provided herein, the undersigned
acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transaction designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition of any Securities, even
if any such sale or disposition transaction or transactions would be made or executed by or on behalf of someone other than the undersigned. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The restrictions described in the foregoing paragraph shall not apply to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transactions relating to Securities acquired in open market transactions after the completion of the Public
Offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers of Securities as a bona fide gift or to a charitable organization or
<FONT STYLE="white-space:nowrap">non-profit</FONT> educational institution in a transaction not involving a disposition for value; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers of Securities (i)&nbsp;as a result of the operation of law through estate, other testamentary
document or intestate succession, (ii)&nbsp;to any immediate family member of the undersigned or any trust for the direct or indirect benefit of the undersigned or any immediate family member of the undersigned (for purposes of this agreement,
&#8220;immediate family&#8221; shall mean any relationship by blood, marriage or adoption, not more remote than first cousin), (iii) pursuant to a court order, qualified domestic order or in connection
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
with a divorce settlement; <I>provided</I> that such shares remain subject to the terms of this agreement, and, in the case of clause (c)(iii) only, if the undersigned is required to file a
report under Section&nbsp;16(a) of the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock during the Restricted Period, the undersigned shall include a statement in such report to the effect that such transfer
occurred by operation of law or pursuant to a court order, qualified domestic order or in connection with a divorce settlement, as applicable; <I>provided further</I>, that no other public announcement or filing related to such transfer shall be
required or shall be voluntarily made during the Restricted Period; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">distributions of Securities to limited partners, members, nominees, stockholders or holders of similar equity
interests in the undersigned not involving a disposition for value; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers of Securities to a corporation, partnership, limited liability company, investment fund or other
entity that directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with, the undersigned, or is wholly owned by the undersigned and/or by members of the immediate family of the
undersigned, or, in the case of an investment fund, that is managed by, or is under common management with, the undersigned (including, for the avoidance of doubt, a fund managed by the same manager or managing member or general partner or
management company or by an entity controlling, controlled by, or under common control with such manager or managing member or general partner or management company as the undersigned or who shares a common investment advisor with the undersigned);
<I>provided</I> that if the undersigned is required to file a report under Section&nbsp;16(a) of the Exchange Act during the Restricted Period, the undersigned shall include a statement in any such report regarding the circumstances of the transfer;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers to the Company in connection with the exercise or settlement of stock options, restricted stock units
or other equity awards pursuant to any plan or agreement granting such an award to an employee or other service provider of the Company or its affiliates, which plan or agreement is described in the registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> or the Prospectus related to the Public Offering (including in filings with the Securities and Exchange Commission that are incorporated by reference therein); <I>provided</I> that any remaining Common Stock
received upon such exercise or settlement will be subject to the restrictions set forth in this agreement; and <I>provided further </I>if the undersigned is required to file a report under Section&nbsp;16(a) of the Exchange Act during the Restricted
Period, the undersigned shall include a statement in any such report to the effect that (i)&nbsp;such transfer is in connection with the vesting or settlement of restricted stock units or incentive units, or the &#8220;net&#8221; or
&#8220;cashless&#8221; exercise of options or other rights to purchase shares of Common Stock, as applicable, and (ii)&nbsp;the transaction was only with the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">dispositions to the Company upon exercise of the Company&#8217;s right to repurchase or reacquire the
undersigned&#8217;s Securities in the event the undersigned ceases to provide services to the Company pursuant to agreements in effect on the date hereof, which agreements are described in the registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> or the Prospectus related to the Public Offering (including in filings with the Securities and Exchange Commission that are incorporated by reference therein), that permit the Company to repurchase or reacquire,
at cost, such securities upon termination of the undersigned&#8217;s services to the Company or its affiliates; provided that any filing under Section&nbsp;16(a) of the Exchange Act relating to such disposition shall clearly indicate in the
footnotes thereto that the shares were repurchased or reacquired by the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">transfers of shares of Common Stock pursuant to a bona fide third party tender offer, merger, consolidation or
other similar transaction made to all holders of Common Stock involving a &#8220;change of control&#8221; (as defined below) of the Company that occurs after the consummation of the Public Offering, is open to all holders of the Company&#8217;s
capital stock and has been approved by the board of directors of the Company; <I>provided</I>, that if such change of control is not consummated, such shares shall remain subject to all of the restrictions set forth in this agreement (for the
purposes of this clause (i), a &#8220;change of control&#8221; is defined as any bona fide third party tender offer, merger, consolidation or other similar transaction the result of which is that any &#8220;person&#8221; (as defined in
Section&nbsp;13(d)(3) of the Exchange Act), or group of persons, other than the Company, becomes or would become the beneficial owner (as defined in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and
<FONT STYLE="white-space:nowrap">13d-5</FONT> of the Exchange Act) of 50% or more of the total voting power of the voting stock of the Company (or the surviving entity)); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if permitted by the Company&#8217;s bylaws, corporate policies and any applicable laws, establishing a trading
plan on behalf of a stockholder, officer or director of the Company pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of Common Stock (a
&#8220;<B><FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan</B>&#8221;), <I>provided</I> that (i)&nbsp;such plan does not provide for the transfer of shares of Common Stock during the Restricted Period and (ii)&nbsp;to the extent a public
announcement or filing under the Exchange Act, if any, is required of or voluntarily made by or on behalf of the undersigned or the Company regarding the establishment of such plan, such announcement or filing shall include a statement to the effect
that no transfer of shares of Common Stock may be made under such plan during the Restricted Period; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the sale or transfer of Common Stock pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan entered
into prior to the date hereof (an &#8220;Existing Plan&#8221;), <I>provided</I> that (i)&nbsp;such Existing Plan will not be amended or otherwise modified to increase the Common Stock scheduled for sale thereunder during the Restricted Period and
(ii)&nbsp;to the extent a public filing under the Exchange Act, if any, is required in connection with such sale or transfer, such filing shall include a statement to the effect that the sale or transfer was made pursuant to such Existing Plan;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pledges to any third-party pledgee in a bona fide, arm&#8217;s length transaction, to the extent necessary for
bona fide business purposes, as collateral to secure obligations pursuant to lending or other arrangements between such third parties (or their affiliates or designees) and the undersigned and/or its affiliates or any similar arrangement relating to
a financing agreement for the benefit of the undersigned and/or its affiliates, provided that the terms of such pledge shall provide that the underlying Securities may not be transferred to the pledgee until the expiration of the Restricted Period;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent the undersigned is named as a Selling Stockholder in the Underwriting Agreement, the transfer of
the Undersigned&#8217;s Securities pursuant to the terms of the Underwriting Agreement to the Underwriter in connection with the public offering contemplated by the Underwriting Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>provided</I> that in the case of any gift, transfer, distribution or pledge pursuant to clause (b), (c), (d), (e) or (k), each donee,
transferee, distributee or pledgee, as applicable, shall sign and deliver a lock up letter substantially in the form of this agreement; and provided, further, that in the case of any gift, transfer or distribution pursuant to clause (a), (b),
(c)(i)-(ii), (d) or (k), no filing under Section&nbsp;16(a) of the Exchange Act, reporting a reduction in beneficial ownership of shares of Common Stock or other Securities, shall be voluntarily made and if such a filing is required, such filing
must disclose that such transfer was made pursuant to a valid exemption from this lock up agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the undersigned agrees
that, without the prior written consent of the Underwriter, it will not, during the Restricted Period, make any demand for or exercise any right with respect to, the registration of any Securities; provided that, to the extent the undersigned has
existing demand and/or piggyback registration rights pursuant to an agreement with the Company that is described in the registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> or the Prospectus related to the Public Offering
(including in filings with the Securities and Exchange Commission that are incorporated by reference therein), the foregoing shall not prohibit the undersigned from notifying the Company privately that it is or will be exercising its demand and/or
piggyback registration rights following the expiration of the Restricted Period and undertaking any preparations related thereto so long as no public announcement of such demand or exercise of rights and no publicly available registration statement,
prospectus supplement or other document or filing shall be made by the Company or the undersigned during the Restricted Period. The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#8217;s transfer
agent and registrar against the transfer of the undersigned&#8217;s Securities except in compliance with the foregoing restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If,
prior to the expiration of the Restricted Period, the Underwriter consents at its discretion to release any Securities held by any Sponsor Investor (as such term is defined in that certain Registration Rights Agreement, dated as of June&nbsp;9,
2021, by and among the Company and each of the other persons from time to time party thereto) from the restrictions of any <FONT STYLE="white-space:nowrap">lock-up</FONT> arrangement substantially identical to that set forth in this agreement and
entered into in connection with the Public Offering (any such release being a &#8220;<B>Triggering Release</B>&#8221; and such party receiving </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such release being a &#8220;<B>Triggering Release Party</B>&#8221;), then a number of the undersigned&#8217;s Securities subject to this agreement shall also be released from the restrictions set
forth herein on a <I>pro rata</I> basis, such number of Securities being the total number of Securities held by the undersigned on the date of the Triggering Release that are subject to this agreement multiplied by a fraction, the numerator of which
shall be the number of Securities released pursuant to the Triggering Release and the denominator of which shall be the total number of Securities held by the Triggering Release Party on such date. Notwithstanding the foregoing, such Triggering
Release shall not be applied (a)&nbsp;if the aggregate number of shares of Common Stock affected by such discretionary release, waiver, or termination, in whole or in part, is less than or equal to 1.0% of the fully-diluted capitalization of the
Company as measured immediately prior to the consummation of the Public Offering; or (b)&nbsp;in the event of any primary or secondary public offering or sale of Common Stock that is underwritten (the &#8220;<B>Underwritten Sale</B>&#8221;) during
the Restricted Period in a transaction that complies with the terms of the Underwriting Agreement; <I>provided</I> that if the undersigned has a contractual right to demand or require the registration of the undersigned&#8217;s Securities or
otherwise &#8220;piggyback&#8221; on a registration statement filed by the Company for the offer and sale of its Securities, the undersigned is offered the opportunity to participate on a <I>pro rata</I> basis in the Underwritten Sale consistent
with such contractual rights and the undersigned is released from its lockup restrictions set forth herein to the extent of the undersigned&#8217;s participation in such Underwritten Sale or such contractual rights are waived pursuant to the terms
thereof. In the event of a Triggering Release, the Company shall use commercially reasonable efforts to notify the undersigned within five business days of the occurrence of such Triggering Release, which notification obligation may be satisfied by
the issuance of a press release through a major news service, or on a Form <FONT STYLE="white-space:nowrap">8-K,</FONT> announcing such Triggering Release; <I>provided</I> that the failure by the Company to give such notice shall not give rise to
any claim or liability against the Company or the Underwriter except, in respect of the Company, in the case of bad faith on the part of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that the Company and the Underwriter are relying upon this agreement in proceeding toward consummation of the
Public Offering. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned&#8217;s heirs, legal representatives, successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and agrees that the Underwriter has not provided any recommendation or investment advice nor has the Underwriter
solicited any action from the undersigned with respect to the Public Offering of the Shares and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned
further acknowledges and agrees that, although the Underwriter may provide certain Regulation Best Interest and Form CRS disclosures or other related documentation to the undersigned in connection with the Public Offering, the Underwriter is not
making a recommendation to&nbsp;the undersigned to participate in the Public Offering or sell any Shares at the price determined in the Public Offering, and nothing set forth in such disclosures or documentation is intended to suggest that the
Underwriter is making such a recommendation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether or not the Public Offering actually occurs depends on a number of factors, including
market conditions. Any Public Offering will only be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company, the Selling Stockholders and the Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained herein, this agreement will automatically terminate and the undersigned will be released
from all of his, her or its obligations hereunder upon the earliest to occur, if any, of (i)&nbsp;prior to the execution of the Underwriting Agreement, the Company on the one hand, or the Underwriter on the other hand, advises the other in writing
that it has (or, in the case of the Company, it and/or the Selling Stockholders have) determined not to proceed with the Public Offering, (ii)&nbsp;the Underwriting Agreement is executed but is terminated (other than the provisions thereof which
survive termination) prior to payment for and delivery of the Common Stock to be sold thereunder and (iii)&nbsp;March&nbsp;16, 2026, in the event that the Underwriting Agreement has not been executed by such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This agreement may be executed and delivered via facsimile, electronic mail (including .pdf or any electronic signature complying with the
U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or www.echosign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This agreement shall be governed by and construed in accordance with the laws of the State of New York. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>IF A NATURAL PERSON:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IF AN ENTITY OR TRUST:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><I>(please print full name)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>(please print complete name of entity)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><I>(duly authorized signature)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>(please print full name)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><I>(please print full title)</I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Address:</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to the
Lock-Up Agreement</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d116309dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g116309g0228121104881.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ROPES &amp; GRAY LLP</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PRUDENTIAL TOWER</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">800 BOYLSTON STREET</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BOSTON, MA 02199-3600</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">WWW.ROPESGRAY.COM</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;2, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LifeStance
Health Group, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4800 N. Scottsdale Road, Suite 2500 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scottsdale, AZ 85251 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> filed on May 21, 2024
(Registration No.</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;333-279585)</FONT> </U> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to LifeStance Health Group, Inc., a Delaware corporation (the &#8220;<U>Company</U>&#8221;) in connection with the
sale of 25,000,000 shares of common stock, $0.01 par value per share (the &#8220;<U>Shares</U>&#8221;), of the Company pursuant to the above-referenced registration statement (the &#8220;<U>Registration Statement</U>&#8221;), filed by the Company
with the Securities and Exchange Commission (the &#8220;<U>Commission</U>&#8221;) under the Securities Act of 1933 (the &#8220;<U>Securities Act</U>&#8221;). The Shares are being sold pursuant to an underwriting agreement, dated February 25, 2026,
among the Company, J.P. Morgan Securities LLC, and the selling stockholders named in Schedule II thereto (the &#8220;<U>Selling Stockholders</U>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this opinion letter, we have examined such certificates, documents and records and have made such investigation of fact and
such examination of law as we have deemed appropriate in order to enable us to render the opinions set forth herein. In conducting such investigation, we have relied, without independent verification, upon certificates of officers of the Company,
public officials and other appropriate persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinions expressed below are limited to the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing, we are of the opinion that the Shares have been duly authorized and are validly issued, fully paid
and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to your filing this opinion as an exhibit to the
Registration Statement and to the use of our name therein and in the related prospectus under the caption &#8220;Legal Matters.&#8221; In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required
under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Ropes&nbsp;&amp; Gray LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ropes&nbsp;&amp; Gray LLP</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>lfst-20260225.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2604_Latest Build:20260220.7 -->
<!-- Creation date: 3/3/2026 2:00:05 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:lfst="http://lifestance.com/20260225"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://lifestance.com/20260225"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfst-20260225_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfst-20260225_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lfst-20260225_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2604_Latest Build:20260220.7 -->
<!-- Creation date: 3/3/2026 2:00:05 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lfst-20260225_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2604_Latest Build:20260220.7 -->
<!-- Creation date: 3/3/2026 2:00:05 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lfst-20260225.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g116309g0228121104881.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g116309g0228121104881.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !/ #\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#M/@_\$?"V
MO_L*ZE\1'AO[+QUI]EJ5[;:_9:C<17$<D#R&/H^W " 8QTKZ2\1?$[Q';?L&
MR^.(]1=/%!\&QWG]H+PXG:!<RCT;))SZUY5\ ?\ E&3XC_[ ^M_^A35UGBD8
M_P""9DF>/^*%A_\ 1*5ZM1\T[2U]X\2BE"FN72\+_/N>:?$_X.>'?@S^S-X&
M^*OA(7VF?$..31[VX\0B^E>YO7N&C\Y9R6Q(K;S\I'8>]>Q?M]PIJ/PK\%6L
MV_[/>>,])MYT1V3?&[.K*2"#@@D5RG[4/_)@OA#_ *]_#O\ Z%!77?MW?\DV
M^'O_ &/&C?\ HQJ49.4H-O6[_0J45&%2,5IRQ_4YSQ+\-='_ &>_VH/@NG@!
MKWP_IOBF?4+#5]*2^FEM+E([<2(QCD9@&#'J/04WQC\./#OQ7_;TU'1/%>GG
M5])@\$0W4=J]Q+&BRBYVA_D9><,1^-=;^T;_ ,G-_LV?]A35?_2,57TW_E(G
MK'_8@Q?^E8J5*5E*^O*_S*E"/,X6TYUIT^%%?]L*!/@+^R%K&E^ #+X9MOM%
MO91M:3R>9#'/<#S=DC,6!8,PSG^(XKBOB#\*O#O[-GC[X.:G\.;:?PY>:M+>
MV.J/%<R.-0C%A)*#.K,0[!U#;L=?PKV7]MGX?7_Q)_9J\8:;I437&IVL4>I6
M\"]96@D64J/4E5; ]<5H>#[#P5^U!\//AUXXGA>\6SA-W9^5.\?V>=X6@G1@
MIY*Y=<'TS40J<M-2?=W^:TN:5*7-5<5O96\K/6WX'Q?\,/A%KVO_ +"-WXHM
M?'NL)I-E#?7L_@^<J-+O(H9G:2%S&%E D"DG#]3TQ7TY\8_$%IXK_P""?FMZ
MQ8Z?'I%G>^#8YH;"+[ELIA3$:_[*]!["O-?@#_RC*\1_]@?6_P#T*:NL\4?\
MHS)/^Q%A_P#1*UO4;E/7I,YJ,5&GIU@9?[4/_)@OA#_KW\._^A05T_[?T$UU
M\)_ \%M=-97$OC/24BND0.87+.%<*>"5.#@\'%<Q^U#_ ,F"^$/^O?P[_P"A
M05UW[=W_ "3;X>_]CQHW_HQJSA\4/\3_ $-*FL:G^&/ZG4^%OV:+Z/XFZ-XZ
M\<_$'5_'VKZ%'*FD07-K!9VUFTB[7D$<2@,Y7C)_H,>5>./!.H^//V]M2T_3
M/%^L>#)T\#PS-?:)Y7FR*+K'EMYB,-N2#TSE17V17S'IO_*1/6/^Q!B_]*Q6
M-*I)N3?1'16I0BHQ762[_GN?0/@OP]=>%O"]AI-]K=]XDNK9"DFJ:EL^T7!+
M$Y?8JKG!QP!P!7S;\)5/[-O[3'B#X82GR?!/C59O$?AHL<1VMRHS=VH[ 8&\
M#T ]:]7_ &E_BYJ7P2^&7_"2Z596NH7?]I65EY-X6$>V:=8V/RD'(#$CWKQ'
M_@H9(]C<_"6_MW,%[#JUZD<Z'#JK64FX ^^!11BY.SVE?[UJ/$2C!<T=X6^Y
MZ'0_"3X$^,O"?[$&L_#?4[""'Q;<Z=J=O%:I=(\9>8R&,>8#M&=PY[5VMI\$
M]4U_]D&U^%VJ2QZ5K,WAA-(FD#"5(9Q"%ZK]Y0PY([=*\/U[Q=XM;PKXF^*\
M7C'6X-6TOQR='M](CN?^);]B2Z2'R6@Q@Y5B2QYS7V?K^HMI&A:C?(@D>UMI
M)U1NC%5+8/Y5G*K)N_G?YFD*,$K=E;Y'Q_XD^&_QK^+7PH\)?"+7/ ^E^&M.
MTV:PCU/Q2FLQW$,MO:E2#! HW[W"+PV #^GL'[5WPN\0_%+P;X1T[PU:Q7=S
MIWBG3=3N%EG6(+;PNQD8%NI (XZFO$K.R\8ZQ^R]=?&R3XD>)8O&1MIM8BMX
MKH+IT:)*P%O]FQM*;5_7\_2/VA?&^NWOP1^&FJ:?J][H%[X@U?2([N?2IC#(
M([A"9%5AT'/Z"J=67,FDE8A48\K3;=TON6Q]*5\R^.?!OQ*\+?M5W?Q(\*^"
MK;Q?I%SX9BT;RWUF*Q=)1,9"?G!)   Z=_:I=0M_$'P3^/GPWT>R\::_XC\/
M^+&O+6\T_P 0W(NC$T46]9(WV@J<G&/:L_\ ;J\=>)?"6C>%H?#&MWVBW1:\
MU*Y>PF,;2PV\2DJV.JY<?E6=.3@]-;FU6*J+72S.H^,G@+QM^T)^SSJ&E7N@
MVG@[QBMY#>VFFSZBMW SV\ZR1AYHU  <*1TXR,UP'Q(^&_Q6_:@\2>#+/Q-X
M*M/AUH>@2W%W=WSZO%?R7$SP-$J0I&.%RV<MCCZ<^B?&WQ?J^B:S\%O$FGZI
M<V>C7NO06.I6\,A6*XBNHB$\Q>APP!&>F:3X_P"J:YJOQ4^%_@O0=:OM&;5'
MU&\O6L9C$SPPVQV!B.V]E_$5<:KCLEUMY?UYF<Z,9_$WTOMK;;I^5CQN_LGO
MO$NN_ V&)AJFH?$+^WG;;PFE'9>-,3]0(QZDU]A^-?\ D3=>_P"O"X_]%M7R
M7X&\67^H_'6W^*-S*@T/QVVI^&=-!0 VT=J,VK;O64PS'ZD5[#\$-3O-8_9)
MT2]U"[GOKR;P_,TMQ<R&220[7Y9CR3]:Q9O%F!^SKX(L_B3^Q1X;\+W\\UM9
M:MI,UK++;D"1%::3)7((S]15;]JG0H?"_P +/A=HUO(\MOIWBG1;2-Y2-[+'
ME 3CC.!67\&?BI<?!_\ 8U\">(5\,W_B.PMK&:2]-C+$AM8EDD)D;>PR.V!D
MU;_:UUJ7Q?\ !KX;:MIA%A/JGB/2+JU-ROF"!I S(7 ^]M+#(!YQ1U%IRFU\
M>?\ DXWX _\ 7_J7_I,*YS]IC2SXR^+C:'C>MI\.]=NBH[-+MC7]5IDVG>)O
M#W[3OPX/Q0U2W\4-=PWL7AVXTF'[)!9W(CS*983N+EDP V_ ]*ZO3;(^*/VL
M?B,C@/%8>$;+2^>QG>20C\@*-A[W.7^(<[>,/V%M \0Q9:[TK2]+UF,CJ'MF
MB9C_ -\J]==HT\7C?]K9M4C_ 'EKH'@V'RV'($MY,7_]%Q_K69^S-IJ^./V/
M+;PW,-Y-EJ&B2!NQ$DL8_($50_8;GN_$OACQ+XKOXREU=3V>C_-UVV-K'"?_
M !\N:.X+5HXCPKX:N->_X)^Z#?6 ;^U?#Y?7+-D^\'M[J1VQ]8_,'XU[%\"@
M@_9"\.F-E96\-NV5.1DQN3^IKQ/PS\1+_P"'7PYU;]GE-$N+KX@%KS2M,998
MA:36T[N4N6D+_+A)"2A&[C&.:]E_9_\ "U[X:\$>-_AC.YV:#>SV5A<L05:U
MN(A+&< Y&TR.,'T%#%'='F_AS_E&G+_V+5U_Z-DJ]\;_ /DW?X'?]AGP]_Z+
M%>:/\6(_!O[.NH?L_P"K:%J"?$2*RGTB&"!X7MIR\C%)1+Y@"J0W0\UZ_P#'
M?PSJ=O\  [X/Z6]K_IVGZWH27,0D7]V8TP_.<'!'8G/:GU%T^1L_'G_DXWX
M_P#7_J7_ *3"N<\$^&/%_CCXW_&76O#/C;_A$HXM7MM+E4:5#>^?Y%LF.9#\
MN-Q&!ZUUOQPTRZN_V@_@5<PQ%X+:^U$S/N V VP X)R?PJY^RI97(T#QUJMW
M$8I]6\7ZG=X+ DIO5$/!/9*70JUY&-^Q9%/HWA'QQX;N[C[5>:)XMU"VDFV!
M/,W%7W;1PN26.!TS3_V'O^2/ZI_V,FI_^CS5OX"Z9<Z#\;OCE92Q%+6YU>TU
M*!]P(;S8/GX!R.0.M)^Q=IEUI7PFU.&[A,,I\1:DX4L&^4S$@\$T/J$>A__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 25, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001845257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 25,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LifeStance Health Group, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-1832801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4800 N. Scottsdale Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Scottsdale<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AZ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">85251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">767-2100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFST<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d116309d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d116309d8k.htm">d116309d8k.htm</File>
    <File>lfst-20260225.xsd</File>
    <File>lfst-20260225_lab.xml</File>
    <File>lfst-20260225_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d116309d8k.htm": {
   "nsprefix": "lfst",
   "nsuri": "http://lifestance.com/20260225",
   "dts": {
    "inline": {
     "local": [
      "d116309d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "lfst-20260225.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "lfst-20260225_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfst-20260225_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2026-02-25_to_2026-02-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d116309d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2026-02-25_to_2026-02-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d116309d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://lifestance.com//20260225/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-26-085507-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-085507-xbrl.zip
M4$L#!!0    ( ,:#8EPFAV8NP!   "AP   .    9#$Q-C,P.60X:RYH=&WM
M/6ESXKBVW_,K5/2;&5(5P#:0$$*XE:'I'NYD*\C4G7I?IH0M@JJ-[9%, O?7
MWW,DVY@M[$EZ.EV5#D;;T=D7R:G]:S1PR1,3DOO>Y2]FWOB%,,_V'>X]7OYR
MU6FT6K_\JWY4ZX?0#;IZLNHP?IGIAV%0+11&7>'F);/SC_Y3 1H*EF&5,U''
MH<R%XX#)I'>/RF[>%X^%N&6JN^=[WG"0='Y^?LZKZ7& $XH"CBA IQST8H+;
M\;B1R[UO4\.>BVJ0>7Y^7E"M<=>YGLD"EF$4"]C<I9(EW7LR3+J[O,=D2#V;
MY6U_@)"?&M8$^I'DBV" ><W"GS?7';O/!C3'/3U%@J)0+(7GO "M<4<N_9)E
MGKT ?-0C&3!:UM>$OAYLE?WY:_MZTCU<W'_2M1 *ZLF>+P8T!&;!F<HYP\I9
MIZE)<L ,4Q/%S+%JGDJN:":XA,7Y2UN=P2*V.C-,&74^+>C&J.MR-D$&SR"C
M,^K KY"'+JM7<K_7"OKC46W 0DIP>([]/>1/EYF&[X7,"W,/P)@98NNGRTS(
M1F%!35> 404](2&DUO6=<;WF\"<BP['++C,.EX%+Q\CY+%,G-3ZJ8F\FHL_<
M<9BG/T.76\WVQ*,#',MX]6K / =^PB\N?8P@&(5MUH/FH5#8_0OY5%&I_%?H
MIYXRA#N7&3YZREGGY4R]1UW):H6IE>96QA&_*:#^@N7_:GJ FG$#UA?4;7D.
M&_W.QID4?$LZ; 9GW0 1JI3*5OEL'K["#)H$ZS$!^HM)>$9QKDHE>+#6(;6%
M6@GUTV5&\D'@)M_U!6X2]4@N5ACYD73B9BILX2,GK%ZD$.UV:H?J6?I#H1^5
MW%0C]"IJK8'>>!A3Q$H>N8-?]#@31*&0+93J1NOW:0+-#D:H%\X?  5])WD$
M@1;A9QJR^@2V>.2D;0*KLZ1OW)(LFZQ3F,).@LT)]@II\2N F,*OE+#BJ!QU
M^:-7M6$O3&2FVY^Y$_:KE7R9>Q>IOB[KA1<#*AZYE\//54*'H1]_(_AC/_IJ
M9CK4EKD^4^U@E8-DDM /JJG'KA^&_D!]T_4% !]_8P8C(GV7.^23H?YEZC]_
M,D^-BP5[2R]67+V8M?EB0;Q4:N(*3$/FMT%Z0**<Y/]E5;.2//?H@+OCZ@,?
M,$ENV3-I^P/J7:BV9PUYUW>=BP5D^N.V]=#\3#H/5P_-3JT0+ ''>"5P.LW&
M'^W60ZO9(5>WGTGSS\9O5[=?FZ1Q=W/3ZG1:=[<[P6CM \;_7'5^:]U^?;B[
M/2&?\XT\L8QRZ7P&KLFBIVNPYX0C@LT$*\V<IULQ9]Z ;M/\>:'%U3)_FM_^
MFN*:9O"7V/STE?CJRUW[AM1D0+U$)?5YR'+PC<W ;#X+&F3J2YV)S[X]1%\B
MY<UL[DL4C=.,]IJF+76M@'#5/QCH0 RT%Z$'M=1NWCZ0=O/^KOWP]DKH?BCD
MD'HA"7W283:RH$:9622^(&8YZQR_/91^CX1]A@ .!0\YC&^.[#[U'AFYLD,"
MS>9YL;0<3@W%*P"*?A&"TV:!+T*2C9\9!;\(0EO"GJ G$:J9.<?5Y8%'K"ON
ME7/5U#[7QDI#AX"H.,*J Q,,8'C?H>,Q0,2\M%(Y ^W&NF)(Q5AS@%4^(3C5
MO)[Y4#"'4#!6:1\<N)2?=*#89H]<8G(@O(66'6Q0)5._YCW644D"\ANC;M@G
M7X4_#$Y(R[/S*[AF,R5B[ ,SV>:(@K) C&@1C3%!J"2=@-D83#F$>Z052M+H
M0T#$Q*SR^^#VY=R^ VZ.:B'MNHS8S'71E\+,:,;(J.> .D[\'*T4[=7V79<&
MDE7C#R\S28JCT!G4V# -XZ<8=]'*52."MFK$42/ )]3_SG0H6BS]A%F#=,,3
M$R&WJ1NA5V]XME,TVEIO= SJ7._T-+5"!**(6P/ZR')=P>@WS(ERAU7IDP_L
ML#:63$6FE^ #ZBY40FD/>58V5^HH4!^^  .IE!$HF) U_*$7BG'#=W:R@)@X
MQ4Q'R +A/^&RTR;P' PX<^DSF,:ESG7HK$/NA+=7=-\2?UL'(!K!7[C+H*T+
M2VUM $P#DU)FKF24SBI+L?4/0MH#';6BE)NML+0S!DT(XTYS9J5H50QS#10>
M0,(K6PKXMI9\+T%X5ND$#$_N("H0Y-\0%$B'J^!E(S?#/ !PX%E,Z2_E0+R2
M!+PM51K^8,"E? ]$0 5'M'S^./AOM3ND.0A<?\S$FU-@6E626S\_(8328_ ?
M>GR+_4<5C+]K!U*%)/OP(,O&7GS 4N6]^8!O&^RM,.97CB.8E-&O:XBVS!T,
MN96IERJ&06[SI&/#IJ1#@17;/G5VBH+-=X$8:P?$%#/USA \+6*5#6,1+@Z@
MF-]*#"(QW7LT%)&B 1_OQ(/_[.U CQ+0(V'067J<+,]%3D&BO*\[<0\A%%<'
M1 X6D)GE3/U*\/_Z'GVE>"S6M7/AP<'H>N_#_MW_Y\%6P>T$55@3*EOEY7'$
M^PH@5N N&V$'$W7W MB,!]0ES1&SAR%_8N2N!ZX%D\?O*L+, A4)DO%X#ND+
MO)T-RQ-[4?Z3G.?/GRJ6>78AR0-S6=#WO=A?5ME;=X@.$[D"QE ;>J%,@7H)
M^^W(OF>9^JEAS1\^VCIHO_:!G/>XL9WC]$JF?G9ZEK/,13;LY9KKYH[LM@RR
MGQCB"^AFB*AO58Y<D.@Q$L83PGN8%_<>F4,ZJ/O)-95A5.SZR)0?JO"\2O0S
M]4:?V=]4B90&8$D#P3%!TO5'I,M<_QGIAHU(SM4BI8X6*+8F/>ZB'N"2<#QX
MZ0#=0Y](/ABZ(?68/Y3NF$B0)-D;JQ6B 7X7$*8COZAT*R;5EB',(PCUQG%;
M#X(O_QG'H1? ,8,@J_OCIC@TW&OH-Q?O36+!^:!S)BA=RP1G%D9Y/UV\;*F0
M*5]0BO\1/ 0Z8J9FZ$6QN=S9@>OZOMNE0,,0."ZM.,^1#N=GI=+%O-[<S +K
M?:7X@4RS -G9?,XM%N$*D)-&%@E2!R;:0V"KDE6.6'KFB *>3,B:9Z3QI4VL
MHI&'CIOD0#[X?'L^[X RMX$*WN,-*$+0AN[!F-PROF<FGR *IM:8FN?PE1;#
M+-&<:<5&8R(,4X=T8E%8.9M5,O)ZQN.4>_4A-0>7FGO!T#+@P7=U2!$-OH!(
M:POG>6WI,;]GZ5G)RH#1G)U":2PBJVS*&A+GY*QL]WB_,J?G_)"ZMY2ZEI1#
M)EY%]JP/V=M*]HHL5\K:^Y6]:,ZU9>\MLD<IWU:'<TQ 0!@L/4&,RB2.\0 C
MRT.Z]U_N^S@OMETR>(U4RRX9^#<M<3_@G55]N-ON$]NE4NZEI+4USMX=@@1%
M0:QU1:'>&0^@6U;NYSC&/P9%M]%A9,5"+#(?"F&^1T &X-N)JITV"N^DS+\\
M!M?68FQ:724IVR?@K6*FCBX2H*03^O:W$Q)009ZH.V3D_XR\89( ;]#V%Q[;
M?)W"T#(D1"*@N7\'#)0R]>LOG8?WMKV8QK'CL]6=@EE_%<5@KA2,MZ@?P(^X
MI=*A?VL^(#=4?&,AN;YN+$3,*_E.F7K+<]"?9*0[)K9*Q<.,WT!^F3J?.)/_
MYI* 0P@^*2[Z2!Z%_QSVT2T-,"=.)7%8CWOZ)H+.,!IE,G\#:G+QJ4BR2-^S
MB^C>#N8:XR&P&) FP)L,6-!9T\.UNKDDG;/>W:O5DT[#B#[OW"HI8/.[7>9:
M3;/F8OS__*EBGD- ]'+M/A[\58UMZ*&'"]1.7PC4#HNE5N\%7CT!#EW(^'RN
MYM,'MF8N1 ? UIZO8H6A9*H7("RJ+.$K2[@J&ND7"B""U%KN&!=_YK TBH@'
M\$&+8$]<PC@0%NK9F+FDMHT7!; SOKS$H<*1NJ;DO!BH%+,T"532S)V/N"%!
M_K+X99U7!RRM</ZCWD(P5? \.EK,FFPPQYGX5<J)Z3*@/3@Q[C,=2_31 &E'
MM7[B[T  YXOJIW/U[R+>3S!*!VFVRZA "]A78=#1BJKR?M\S<32;XOKUKOVY
MV<XU[JZOK^X[S6K\X7M(<9GFFCFNE\_'M$(VP',GAGE1R>.-A_7.[KQZKNDE
MQUVOKN\=-/$NKR2;Y&J65?O5"J!-84),*&ZFI.\\LOCF[@EY\8HFR:+"0XI8
M(+YIVBEP'&9'=QBJ*L6%JD,YXJC[(^*IP>;%,5%"I'P6T*XPT1\XXEGHTM+5
MHV J![?5BHNGF@4 +!!H?$(A2GA4BKP1&ZE_Y^_SY,87C[!:RHL!KW$W</"4
M_10,)PH"G%*"Y&DK!&YJ'UB(":F<".74X7O*''3$6BWL+1B@;!M(.M$JG=0J
M<R )YE*%.5@$UQC&X&-MV\<$LSJPT2/ -*#-\4<SD8JGY': J:&S%(H,;"-Q
MM/0!-%M'=G)%9+<MLR91XQQFTO[ (L!B]T5Y).J0JF)A>%CO'$TG5XR]VZRZ
MD+)RQ*V?U[@O%HLYZ^R\7"D?GZ3.X@#[P.HW-!9S4XEY:2O4M-.[Z\2[FT%2
M'O0$08N"O>8QME@R3]+85)X?Q29U= AF /<*/+^>\ ?3<P"ASV(.))J#T-%P
M4+)U #+'[7-PX/%%&A(*3A\'E3=A'O;W$/S#J/ML8T!YLDH:G*C[@H7SY&&F
MK\.U8RN8S?" *FX=75?F28UB]&4CD9H(0L*<I,MP"<%B!"4 17C,DRU<_9VL
MRI7K)K&?AAMQI>%<01>I\1.SP"+<@%=N T_("2/$NDB/M5U?1HHIW4A\&Q2X
MB 4!<!6)@C9X>JS#I"UXD#Y^ML0<0<")C)%<_.=@SO'>$JCD<;P_H.Y T4P.
M[;YF9<WE.CVGSL;%]_U@%M3G,!,,3MXBIPU3&%+4^YJKN(S> 8+Q?G/4YUT>
M1L%(WGQ]6K?]@$F]_L]T$%R ET#'8"'O3PA&5&#.9I3DB9)KCK5*!\V]'W /
MT3W="U4HQ& \LLAIH08431/]"E8*DB.!\7R )ZWW)F@BY;R9(+&!S.#%1U"1
M*58J653>>JN5W._YE0=X*SN6MC_\_K3??_Y]^_U?DE1#8C&EDNZ(-V5^+]'
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MSK">\&@0=EA ^.F<SQ^^9BY23Q*7N).KI@6'=%[.UOCW&O\N]Q$\HZRB.?Z
MGC9-_0]!MU0IB%B*JJ(1B32G.RL6Z*WQI98MX.\W$_]9H/P;HZUZMBAI6/N
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MZ+4Q1Q \VO0*36>];Y,O7@N-1QO44/09:*$79.2+4)$;.E?XPUFRRAI$)!(
MT1X#7+8&U0$,Q$ U<:M@HP<T"0S>J1(<G=$,<G;^G<Y%R' 4,65)%VNJ-4DR
M_NC[GW]_?6Y-W4LPAG;K53)+ORO*ZRI9??-#41:[25UCP D$[/MO\?L_\ '%
M).LU^M1SV/)98Y;?_JN%VB!S"7\X \FI*/0%"P4>5@&KF!:S]7):45 J'H]H
M/=CW@J\GV5*@U7KII<H'-]Q4:1YBF::_3-:T.RX*$"A$X)>5PXMOG/_!_N[?
MS*R-D7R#X^?PX4_I+%U.P8)DJ/D!E;8]IK6A2#[%<,!GH&. 12IZ H&L+=Q>
M&T>TNW^X<STQ@X+IGEEK?_-\WN[^P_RR'^OK+^%G<*\NT*#5;G;K'G4"'POV
M4$1?H(>!E(31W>UZ$__)5(!@SI+_B(=/'U^PF:]&V%(OOL) N'F)J+*$,NPY
MJ$>*1C2J?(BOQQ5GRAL&I/G@RON_,Q]^(2]Y(:V:'H_\$B*'[E7).W-1Y?-6
M898'!(+#M&[LC14$_'4TN:^]43R-8C>:_,.T^)[1  ]^KC->^!ZX<.L"*1?N
MU(*Y008F1CL[7V-;99IG%Q("L15?6H6,1Z%]59I@8@,'= *J!$%/"-A@94_(
MU:J\RFHQBI4=!K9SW$(HS,! 8F.(@<>^];QQ!Z<WNVB06ZUO+ =M=B<:1MDZ
M_&45N<519@7H?"_)3X:.U;+V-5D!YYR>'$TS\116+?O(>X5_TY&5!XMO+:U6
M-F5;TPI>X=+Q^,._UO,+UCF,5J,:IQE:&B7%F<!<!E$J\"M)/AY-RSFJ_@LP
M-VB\LW)=X5URA1/RG9PKN1LWS\Y"VVS<""0!!"/)8WN6G5O&PUQ0W-LSD"DX
M%7<&'87'K$/FQB[I/Q04E F>BM:A".HZ?2:L&<]9SUHIKQ56YY1KS'J54[DP
M8&3+A.QN.UH96>UL#OC2CU@W_/;=C>=U7L'REH@6QIO%)O0&HYP_9P5,'R7L
M%#P9D%F8NC*/CIU3B97;T8X#_?Y\^OKLV"L_'$)GT/N[B(Z]+S9<?_0U7/]1
M;[J_Z*:K4ANW+F<@_Q7=\3==#Y3Q<K'1.O/T*LW+%5];67%5YE=<PZI!/[T/
M$9<8G?N,KYN%/29&PU]G-;].O@PN#E94@7+300!T\SMIA5MH\-B4@"=-&Q_0
M:S%^!N['NV#BV5H",'Y0?*)B1-$.7?<4T+A!3:=AC/ 4< :3=>ZPTK#KN.$H
M,E9<<.TXD6&0M!B+25:"C:4UA,>7>)=P@ 2OI29KUH80(7'OD96?K_W+ W=Z
M6J?5%?^+;U*L2$$X"XPI8=/ "I3O(3 \ I=ZC1F )>SQ18)R.$>  PZR LT<
M1WE)7!0=6R-Q%EKI61Y@-+A0U196!Z&FL3+YAE?\UK^>EG!'"@*7?RM?IMO6
M!+WP&6!;;["Y.@^OF>]!C!HE!N.1)TWX") 5PA7!1;CF\*DV?MBHB.EFY#25
MO?#DFVPSX#^J:88.&UDBOIWA?EA6-SK\RA>^4R,)B]HL3S MY@0XF9:(JUW(
M.TG61-+PX6Y2G*4/!.\LWD=%[SY>IN A/<[<7 =H7A7E>,3>>'M/=+&$J6_8
MJK A4G4-'W9L!D2_6VFSG<BCYR4RH_@Q]%P3U'9,B> %[,/XB8\7R==CZI7:
MVX2<49G?OSS'@G&AO:$,"N[#-,LQJ-S:(>1C856_G4/ (H!WR'J)@Z:'F60&
M_0R5?[I<Y:;B0.T%&=_WL1FL(ZT[+55X+=R[)RIWE80N;- $8?#.KTOWEA=F
MH/88&P6-(6SEG,02/Y@)O)%DWGGJMSV?[K[!M\J9XDM_70B"\-.M3JL^):G'
MHY3#\3:HV%,T8 >*"[O%,<>DHKS#SNWA-?F24[Z(OP_6_-LA:XJ4_O(EN'-A
M<$0(9NM_U(]))UBH<6, -W9I>B@M#A\-45K$KM#GEI4]'PN5]-";6H0,?BGM
M0 #@>'21D0<F6ENS *EHB8./$WQ3'TA'4U)["-:KM&YH;V?N;A<(*QE4Q!"2
M>7DC?/.I^Z$9M"UV?K2O$>^?@3M53N"?F=S\;I6+#3IO@;A[B@01H #OP+@G
M]\AA-+Z@4+5D%V((H8VI+O+^U/ LL9BO&@U8\6M P>.UZN)Y,*-LM7;6.IM'
MV2S5$FXR"9_!VJ]\R=:US)U%=Z'N*@V1R9D'H(Y0!Q[#/;#@X FD<^0VC$TA
M P**\W(&BH2B?&V5T,;A@Q)M4@LYN5S#!*)+9E_DZ-LB1?>$HA7%55:5A3%8
M+I-_)]6\-+?3>ZP$A8E)S0,BJI,:;VDPEO)\W212=T!>+&IP_+<*#;YT3X>Q
MOZ(PO&8%0,N$_11;Y(I+ F;6$M84; %8F;2H4W7[FPBQBN*RO"Q%2ZOU[+Y>
M US@-UEE-#.&@4R\1I2NCNWW;"/R^A'=!&7GC5-?F_N&*[1I,N"T\U3H0-HH
MMX2$K\D4PJ]CE4[1?D]W'K%&?<C:N04QZQ<-+1_>?.X9IC[5ISKL3DM-J?5\
M]^2[F/IH^WP*D-N7&&%^]#7"_%$U^[_\D )(?,UJ#<X@N8)$R%C7Y8PIU'K.
MI$Z+.L T6K:-Y"HIH"1  Q<31F/H/<4H,.S7RDYM3&\B)JC87:]BD^"<Y66-
MA]JARPP<:*-6,;[3H,IB%I"<"Z4I0EHE&=T#A9H16A!7CLJ2GEHB;@V/LUY7
MNK*R:DZ&.OQAHL(%GQ,Z[3.P0*J.G(IO'+O(+^VA%,@Q= (Q.<UUFG8G[1BD
MH@NJ/40>.-'OM2P2<9!3^$7$LAT2H2JMI(_3HK?DJ,V81->E2FQV@F-TSP5'
MX-'VJ6>X\G:&G1C'(< %T>-5\NT\'GG)VDXT8/M@S(M6OEL?+#\OC;F>]O8@
M'!*G2%O2A>0.#65SGCL _L#Z\#ODN>V\;>1+&?C]X2\4[*F-F?OY\>N$3$./
M*,_C_7KPHUDS'\GKLDAO$=CU?#.7LB17#(/5)7PXXY@DKE-YDTHY+*,@3#2;
M0%=]X6R&I8BPZ<+CJ]!(Q7#=8K#6D[1UEO@O[3UF5'.+XW7),,8 (.7YS5(*
MA;!FF4Q0^!NO01OY88^(\1+EQS:60#,#&YAQWN TIC>QS3+%T46V:,S=!L*,
M]VW.F1AB7>]WA44ON<0"[PA>*>H4\()U=XI*U/5O=8IBEP' XCM5)1%8"Y1?
M]@&T%#)8,[:Y$)P29O8<;BE6-S;J"5QY+IKAI>:Q@LF1S/#!"TY>>36=*CF!
MMN!%2=:+>6R)MS3ZG3:K(?]AGHT3P'N&CB,^W_V$UV2B_<%?W&K\+D]H T<8
MYD-J?0&;0_0[]FTL6;'<!^C!M!1E.Z%,XN@<0KSD=F=E5:T)J!EQ)EF</04Y
M&S(-)):E0BI7%O[/).19I5W)D-\X/")Z SX6LWJ2@&:XXA(M+4X7V_(\E)\,
M6V40IP%_3KLP,X.E7,Q<;$MK,^G@#I["D@,-L,:764I3\@=-=X\=GJJ\'>0R
M</GM%J'?P^GJA@,YPXB,WM .WG9F?_AV<GN/47E4A/3*K' &J%M+H8]M!WXL
MJ@14#YR =VFZ8M6"@1[$W>._=)&S9BX'=>GXO7Y,BG=H;,&#;CA$K3@[X,X_
MSQJI.;54!UR'B>]ZVU1I<0%_)4[@XR6,?I;@K]X@7)->=HS*&&YB/._G90GN
M_ID*SIZBKN(+'![W^Q01")BV/$^K"G1ZO33!U</]_8-HYX^WQ]&;X_.ST]_/
M"3_O8*KM(T)*'<2/3!(R5"5AA _3^,-:@BE;;Z@)!YDC&P]@Y5RDW1K0X@H1
MR !<O3RI^+=QBP( E/\Z0X!N027!IK!DOLP*8Y7BY8% \QGO5 ?/*$C&G1G>
M%A2RRF_:W1B.<;%^H\5ZY1:K&WD30]0HU'J=T07ETK92_R^EQ!X4(C"H6)6D
M8J08H9?F$E'("0? VM)""A&K]D\1;>A LM]:0ZV#KG/]GX%>6O?:D/&@4=9C
M,FZ#=2" JS%8&"J+"L-<;EN9C+W87N9Y1'L*5,>:;06Q<)1)\(8N;L\*$,RS
M(;@(64HHG 6-;XGBR0^I;6+TNP_=S8.C#][.XPFC=4V664+"H.?EHAPX^J27
M]][N13]A&7UC&(_(Q<,K?%VY[21#BC;F9TX?C$?'G.0^X?6*K9J'A[\6?23N
M^ U\:0TWCWSIY1J-9M@U^#:JA5]A^7]+_DKKQKW/#,#%E&W1I)J<U08M;:4:
M2Y@O^XH)<UE?:J#V\== [<<]4S].(DR#=6N^0441NP:Y/GA3@>1SV @,CXQP
M>::2@AQF=2JM'$:;PK>D^"H8%(>[V,/XXQV&/X5B8ZMR(G=]VI"M4VP)GBYS
MUO]V*6X=7-;_+UFA4WSY[\O,O+YNOW^+&LBZW.5N2>;=/X$>;>IWH$++59[:
M4XX!'?(^MYI6YZFOUI=)T?]4ZV"R CDIN=+PK+VJFC)%Q^Q><MD3W$>_H[LX
M'AT\VG_R.(Y.UM,DCDZKA-?L-8&D_P8G)YE\*#3B^8>7;&7=#'+G0B>W F$/
M>$MS\!LL<E $&..++>@'/AR/0E]Q?B%^C?]N4O#S-,DI((SG0@?B;$Z:[U&#
M9A>CKW.4#)N[3]5)03E^0^L%=(E3ZKA](]JS]QF87U>3Z*TET#>VD\H.S\G;
MY\/)J#/-+@=3O$!N[[M"*L>CP<AQ[" %=P$Y6JD"#1>HG3#Y&+[3;038!,:,
M[04[2V,OV)"C(YL5$B1S!6INX]M<PRT&(NI=14'CN;8B==FG5Y;+;YZGLYQI
MBZB*LU1E&-(Y@PSB*U0=W+H+-R";KG5,Z%V&GQ5<<."7_CI<+3CB#$JC-/BZ
M1F[LRCW;18[4'%6="@4'O*41+N>,*X3;DZO!8FIV":8T3Z>TZGE97.B_W*5R
MY.$Q8=>D]VR4>M@=)U&],-R.,)!W:<-,O12XP*!RFJ*KO6(&=HRD@'[/5;S7
M$&7A _J?)+_EP*'ZO?@;;(4OS5'O5F"ZZI[@KOB5HJ%#:33%C!L\;LGQ$'&A
M[X+0A*V*0B$'-2/%(%]&3@:'ZKC'J 5Q:-Z7[B\IZHP$Z"[4MW8G;&Z:KAJ,
M+/U='DV,ROSL5I)I:R(0&US1&X-_G:ZSG+.:EVD^E_PB4U]M\2YI&IF[[>4'
M4)5XS%^M;31,/#*N2\97U"H2RDO/SDYM[F5%.'OOJ]JW#G=:XL_@OGW/X8ZM
M,77"7"2Y?=HQ"U P9QEC.1P;Q?HO@R!?W7#*-":C*KI$VTEG,2M<Y1I#IM+5
MA.^ =<'/XV#[MZ7["TD$AT%!I5127%PLV%K%7&ZA2)SJ&W#RE[4-KU$D'GG"
M\;VHEFKL855=H1=/_^3[GT:%;7;K?A\:PZWT"897WACY.*/9>B$58OBC[ J&
M)6T.P"-$EIRMH3'J)#+H6KN.R("@%D,N\"VGJ7W?#PW/4[-;AMZ+^78%/#UO
M'H_DU2(V'6KBC8'_C7K"!K 1,%A3UY:[%A_IT&RL [.E,/M0$ Q?5:-A ;,M
M+DQDE<9))6@UB']*Y8!VE+:XQ4(4A_;)XS@H;@D^OJ2" X/LI"]3X26.]L+D
M3N&P8 17#.-E5B<VQ> QLGF)O<$AX_&VK0<VKGFA$4@W3"Q&(Z) @#\>7GYG
M<,J8)&6*TS6SF;=^FLY#OZ0< *S!K4^*XK\O7,#8V5A#NV*&6+>'6 >'6'_4
MN2UT^M9&B%\H8GK4["9&;='&B'LJJ]IXOK;^4=5[;Q(3/P^^94*"KA]%E.2N
M&D0(9A><W':UN=>,:Q&;H6\6$F)'"AMZB&)"0X@R#C<6LY7N=V$[(T]":/LV
M'N2VLA-(D$JT.<8T46,;C@[5;9'IV267PK E$MRZ^E53]@4;NW6JG;AK;;:5
M&G$2O?0RK69L4-G+C-!]X$#1/)5HYC<N*RXWG+VGC1[,<]^7AU4TO:/)"'-)
M=S2@M+WPY8**GWR-57]4\_8F;-Z&1-R7\$@5AX 362Z::X,YX'O0N!.UBVRD
MQA.R'9;1GVSW[01U@"5J:[ "[$<J;<U6$5YQRW*>YEXX'-Y!K@R%PX4@&D_3
M;Z?GT2NVIN+H>(5'WOW[E]=_1+^ +5.A,N)HLO?9*[0KJYZOL&+#KQTC9*SL
M^9H'+_H=)_B6)@C_PPO7)::QL);A(CWVO\6_X&H(IRJ-P@V]L0THNJ71-!ZM
MI:+";6]M;F##U*UW'I\3&H<)X8(\%JDP_%N:47F>19SN' =T\L ]R,70V&ZE
M2@5<C093RLEX8UR:D<S*N:*N;=+995'FY84?:W'&RS!D<N='16-UBU=P%"A,
MHS4\4[@$=@[DI;#RB+#O;D-FSA8/!:^3.-HYE)]9E\-"<4WCQ@4&#=Y16QP8
MVA6GV:]+] -QLD?R -@DO><-P8@O065]!@&^?T\,&WY"2DD6:#,^FN.@[6ZX
MFR(XRB3@3A^@M&#9_W>=WT@GEGUD$SUX&M_ZP*LC_BL7S)V@<"&X9"_:O@%[
M^[>=OM(X<=Q]J<J;D89O:YB WBBK$-#"Z>D=;31K@%FGH##B>D(]@$65K(4Y
M<8K74DZ%9ELD10F1\[=L]FZ:S-Y1E@.Y5G8>'1*(X61/$HCCT1"]JM=*Y^AP
M/]E].MV93B:VL(76(;O*\NCG!/&[)T1O2X"RG:,#\RKO.4=/#Y]'*3(F_6MO
M8ELO7U3),OJ9)LO/.\.6Q*8R03WKZ-G^P>[1LX-#^>VLHC)U[":% U"]EY!F
MYC[FFZCY'CQKS:F.#I\]H?TY?/:41]3=/CM&R[!8JRH, I6(=)X6]9JAV6_
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M@SOM^J#!S-AMXEP^+B9:M[1L4H3. $TPZAB1:I9.,FMY:ATJZ59# H&-E5V
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M9!\Y2U6E1)YS@78Y>R>&]_??GOZPQQ11@8^Q4=.5*2K@PH[HKS+#/ LF%RR
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M3C,0G +&,$L5$4GHCKU;T.1>=^+/@"'3:Y(;L%PXT^D'DF+V=FD%C)O+^<Z
M41]9FYZ,3*ZZ,N9*5AF'@9\VA;>G"P8K,M^ ">9(<C+#:Y6YLH7FWV^+WI\N
MNJV-Q6I)%]S4?L6-5((Q#S!22U):@R6IGJUK3?M/L53[$R3C0U0ZSM+0,FL#
M&=01]E&M$"IGV395(TA'5+[7LQ,A[ZJU$10JLS7IVT !:/T%8H_U8RW#H4OY
M^(!:B *(1K),>,9?)J]+B2_@'/?46*UBKA!0?KS(5NLQ!JN;5^J+]80],+(#
MZ<5U:4^+YB[[A-"AIP2[/8&U*!*&77B-,QP8R,QV9K]*EB>I<6^M:D'_U)\'
M+W9I:MZ"-G9B"A13@G*L-K"UDQ%393!$NK"DY:^Q0ES=GE$;.^;LIWR7.84R
M)85@2M4<EW,OFSR'^YNAZ5A-,[N$94QCAU9J 8A]+"9LN(($:R AW"7O"3ML
M$NW680JCHU2S;&E]C1_!"@9.X%,,$,+HGF(T"BX%K(@D;B>2L9522KWUEKXV
MCR7!O7$ES6%CT!*S@CF-3W]S]X'9+X?ZZI>,]G:P#K9Q05$?#ZXX=Z:3\>A'
M!C;03,6$=:O@:E+NH3XXWB"T> 3YW(E)B#@.KO^8]Y;"FAHMT^.9=W&+7Q*K
MF>L5K0>BMJHD-*.0!IMW6"RI W[H"+[N"<3"[S4;<9W<'QT^PEQF+PA%>.+-
M@@;[@VO+C6'3Z\^BF>]L@\9M[[;=KIZ":8-4(Q.0SW&K2T&,02[\(*8&!AKW
MWX*Q*YE9U]([8Y%:'M9MAK*MX'P&.S''7BGL%% !%2Z Z2"%E%72N;I>YT)L
MV.9UU4O'U>9:$OM.Q'BD19-[]1X=X6CZY;UWQ0>VO;,)P3HRBQ]1;.J:8:LU
MG\9"'S^##4R]#22("U.$]J*82J^_H/TA>[VF88'Y5ZQ%0O<O*BOI733;T-Q\
MEMACY*2(W#^DFW?M!6 ZV4IX\E7XU,5X4'KH@@'#^0N.-S[Y&F_\V%G+TT&+
M$!%6PHM1LXC6)5S)R/B*]9!\F:QOV,$Q-9.H?\C^O2_RI@*#F XL3D@Y(>-F
MC)OT)R7DF1P=F M?+5P9[!'4D"'390+I7X1 [V./":;9FMVF2V&#*F3Q@7,<
M&CQZ8[!EC6JW-)C(Z#'&&]Q+O(Q0K<NH[7P5M& X _WA>]&T6D>VF!$I/,T3
M+<UE%_<;FRA>8EK%$961@\Z_+D@I%XB1#,8NV()E8"8,K^)XFS@C<21$L@,A
ML')PBG7IKMY;]'"F'_;QD3F^L<T$3/;8]D(TLQ9Q81(^OC&5/SIZ*QR4FML0
MN5HOIY5,),K+XH+QEB3=;G?[/*S;OYRLW\#;^^7OX1W1"]3HL0D;L/_&KI,K
MU5]D%9:)ZM2KSP1 >ZXU>GV[@][6^3N,-,ZS=&UBN1Q79WR\=C!,,\^#IXCE
MMJ6%GGD[:;=JAI7O!.(#18M8"BS ]+9ESN<XQOC%)[IK-EPO=^1."]VXPZN/
M,?@[+'_[^+LC'[S?/N9-<;?+ 2MZ[^EVZ"3.Y,\L5+ !UY=80>,*E869*^W&
MMTB_M'Q]"TZVWK)B<7:NER%LZ#AL+1>O]RX3K@(9]-VNM*UOL8][<86EGZS4
M>U$^_=(_>.'=ZH[;=,L\-(GN.;:. FFYXC@N-[F[T=?&@LJ7O!YM+F*QH8E<
M-T<OX> 0[+@;$7[18H8D5EM/L?NQ&%.0S3MJYU)&\]*%[\4;]WJ 7'-C]<;X
M-45YC5LN+?]X<X<#1J;.6_@U@WTVL,<&]@E3W64;TBFFNP:F*$1<'9U/%2"_
M8([$Y+U-!V\[(QGF9R![&<D>7907:6$8QK0OJ?;6,;(;/G^OR#F@OPVS$<;*
M7"U00JSO7"6ER%(Q=5=)+1:;68AY0[1D@G3ZUVD.ZGD)T[E$/QH6@;!G]JYA
M2VR1U;,D1YFIFB[4C>O"Z!W6@NM)&.WP]2#L_J[\6&X%C&.I)AIN%J&[#Z6C
MJ1%<#+M>E068AS\E31+]DJ ,TLU^7"3Y#9+,X5*>I<CICDWFWE)?]XG<59*5
MI;'<2*!*&K;20?=;V!STZET+-NCM%=F:P&<5>?R+ BVXG4&")-,S%I'RTC"6
MM"?]>R&L,-)M#0ZO)2XC"\0VXRN[J>,=##VBV4*=?"9Q;_VY #-=9UT/H3E0
M,^4.&(@3W^:V]8!7@8%:.J>4 #R8CV&K*X$M]V0X-AF2/$S0=T?[F#ZM^^DB
MN&&.@B>,1^=X,:S!>CQ3DF+KPP[VGCU_NGN(=QE*T\'>P:-'C^'?L\G.$7=H
M4LSG,.Z2+"C+9B%#.#U[ZT@6Q25ATZ(SH"@X'C>,G<,OF5+TZ==8[4=5(>]8
MA7"N@L*KCA*&[@2,>F33M<D)X->VZ.2Q$7%X#N84O&,7WK'[)]8IU (^-*#V
M$P^.R>86E0!7V#N-B+74Y^&6(YS5VG_<G](B=>Z*I-&TQ/_&FT#L.G+C79TT
M*B)T;GT/O=ZJ6=U]+XHMM8 QLM4G?\'1WX*!O=&/&*2P'X^<[WR/\06*?9 M
MTO!.UXK\ASCSVNX_A_:7*\R6H5Y<=#U49@&2[P2\_+#OK7;RTPHX7+-,9-ZD
M'!ABMAH:3W<O'4?\ U&HV5Q]7I=MJ%DHXQM;S)-D%5'@[%&FUN>!9#%%;)RO
MSGQCPIG!T<7\9CQ"C&=.?DO!]!>RHG$ YR0HFN=R[X>,7]_1QW\[0L*S%-4A
M)5;?T /]%G4[!W*QD[L41RNJ;XZEV3$F1=#X-TRZ_'>.DJQ,$E9_R40 8L>D
MZWV9<9_^(R\0*:J^%DM+9UQOAI'Z3\Y3[/>@*1P4!5N%^I^)6A;#^6G+).\E
MB2W@WFE=&#&Q3C+9( .VTO?8=X[(5_F?S#I!_T:#M?7(\0AL&ND(XMI,TWNN
M$T4\1].],"$]U"TRL9J#4_0MTD_$*R',%0BMC35120I#AM,V8SE%K33CF8+B
M@&==9JM0?IQZD/ P#.1)]6GW+;A9CAEZGA&($'7@-3-D^&LF )OQJ$Z;)F?O
M2U.@M5==\8BZQ:>YSI+ZTM]O?-V1O,Z"M+QNB\-.G6X/X<<*%A\L&^ ?WT(X
M/CTL]YPL=%8*9'AW,I\K++#A/@>F)XAB_L$8'%G]MGDB1:-,!^TV-*I<]*VF
M95J0]9)^DDJSF.,O@7%>;(.,=^W3J4;>UO$$&.):[H>NZQF"].LPI>W "$9%
MEF=-8I",L-T(2\FS^M(9+8WP%JUR(M)4@6<8M:[XMF5]E:T@:<<].J"GC1?Y
MP?[T\:[M^.@L2<T"9+,-FKTRO%%QL%X4VQSI3H,T5<N])%\/OL43 G7?=6ZJ
MENMI216II[&E[4Z*HER#X!DS0Z([X6F[?DLZ=<8USE=ECJ6_5!,<XJH%_9)@
MU? %HSPZVVZ706RRGH'Q2;)VK])4/IF+:5??NW02WJ*A\FS51@PL*PCSB>JL
MQ-=O]]0F</KFI@L1ESXA!2KZN93<AM> L>& YLCV4]ZD*0NXN__IBY,NN:JZ
MZ[!' F>R\:PR>I-.CG\C8L)!#*<[E)O"M']2TW9!P*3OYH!__(P%8]OT@=Q]
M9LX;)EIPN:Y@1,R,C#' P"44R,RB#^<O(V8_P,[GH=E%L9%.7U?$XMQUO_=A
M2\=P]IV7:OFLNN_7[V['W7VIY&7H%@T_<=+7)8_:'=2<E6X+<C\SFZGL5,:&
M27'@?U./CO$(7>HU)0Q I\W7,T[Y->GLLBCS\B*33S"8)SD<,>7@*<PU:GJI
M2CP3Q0/[Q=ZTJ00IY4[G+/*/6>L<6#8T*RK3M$@7X'>P\N'VL?/V2@3%+6#G
M[?#3X5Z[A['X.MM@YZB3E2B8F"LULV;=F#^1->BD@XRUU*9GVP.>M'-<)!$7
M%ZBN\9%+P^RM BD[E-1&92.B1^U::FNZ<7@!=9'<'7-N(S-Q;S#+2F6)Z!2A
M+4[S,@?/MA^QG^C=9@O:'2IG8&&E7BIMY\TL8/@'^_]E&2Q*K.8--,5J'< 6
M5P".@2]593"!3E>TZGXHC5*OJ<>=X=:]]CG>2-J\+,P\17(X,BQQN:GZ%5R
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M1<NXSA68=!-.?TN>YI./*O9QVG2% ;:M=]M![;8W&.N#( GHW&A7S\66V/H
MB4+<%T4/NO55WYM[?A'+?1^8D6?,9)5G75OD .RX ACTOKTM!YJ/>895VX:M
M%3\$Q6FSODF;2O0!R.T.B=CPW(D-D=F-1RT_FU2(;1C1%N+IC73FB"Y@!:TK
M8=<8D\*+1JQWUX NZ5#:^TTL<+E,^J^T(9N>OBVF]?=%6DA!G$HS<\IK76/V
M+26;RX10X'O&F$=$#NXYMBH(M?81"(_L&"[B/\OJG?3\M"!#":^\3NIY\J_H
ME[R<)@0SPH/[&Y%0>^A &;4!@KB;J:5@!B;#J.A4#2#C/VT)UQCLX8(U \2V
M0 8PTEMZ>(VEFY%KH&/#4V"P5&ON*H_Q83<YET6,[8D@LRU-*CHM-?>:M&!7
MOY^.6HQRQN:DQTEOA  3X4CAGJV7E%4LETML,PL?3)/B':<,\=#+H%I+/$_!
MC!1+]6=I2P2#5!M/T3@AAY<FQ#M7#KF&OG9WI'SLUPT%3\C]J6=);E7V90DJ
MV43)14G(SN*%8(GJ>>6M7L)'+"55.:O@ F2[SG2F\#2XC2D8> =U9;>[1B%3
MY#"N^=8A&P)\ 5BOG,.'?J--ZTU)],XTN["WG<Y_P/K$5+,%6VM'%XSHJ<$M
M5Q7N$V=L2+YA?%EM#!B)E[>Z2<34R(&2CSU],T2AH%JKS8U+1F0"OD<5Z+$S
M6$R('[N_/( J/V*>TI=D)* >!@/!L-$&;(YI2AVV4O-UKE(9T-#2"L6 PR21
MQ,5@GWZZIWQ?!%LHNLY&H7P#3)SZ&8G.-6E],IL7ZQI/>6&GV-;# ]7'K:ZB
M3K3X!@-;;H$4YNK6MU").F2L,7#,& KB:JFQD&CW#<:NQ;JPQX2YX[GP98MV
M3!R*8YRBY#>X=[>.122>R1E8[4#+"KRTY<J(I5V%4IP=U^TP,@6'C=>E:L#D
MCDW71PT=\ZHX!?_[X8A&T.2[Y6)W!2]/VVA&&_]0I304"MV.EGZBXB88)K'W
MAU=8%5CS8"K74P$FX63RBIZNLW'=+Y<]_O#H:[KC7B^71]RD#EQB4)56CCK,
MUYZ06:^:C>F4?^S"[9)FWIY /FZG=N,H$'*.O>1N'.SAZ'5JL2US;U]L[5_Z
ML=7J:U<09LZ8&ZM)#S%@K=OPZN&+BJ>33GZJ-R^3S&S:5\+\ RV^#$NBFVRK
MVU\[!ID0,)9@@$MK&N9I<8%]W$PKT8)Y)2.F@P"7Z)J"]V M8X<RW%!N>AS)
M)=*^S?OY/ZU]S3>@*7CQJRF]H,=UZI>^F+4+-T,5%%%9IV:(-'YU.[LX>R=X
MQ)$84=W8FRLMUPXX;,]9K3SIP(<[/D^3UP)";A?]THDK]VG5Z;3#!5RLZBHN
M.:]"*!.#;"GKM&U@#<F:=,^QCEZ!>L $VITC%ZCFZY')_IZ:PB"!^1VNAV>S
MAUS(8B[\+)GKCH8.">+?,8!0EWDVRQI/NTAN(G!9M]43.?/<\AZY+I)FC8XG
M2]Y>I\/ \-F\3M"PEPVF8*+L\@ <CH6* ;A98W?2EA)T$GP5M;H9CR1(;D/Z
M>%W.J,6/=PZ#Z9V6@OBLE.&LGTN7:)=),R@M:)AN;6$ B&V."/2+R\[BX>I*
M%H#Z#B>4HPNH(5HE\PW7Y3;Z$4'RIW+&Z,4_HXU_<O:6Z+ORLEX+EM)"[$B^
MC0&9F.C,T([$W?,$CA>QJR3O* #;.AI#C-&4/0+?<9:MA%; WWSP75)QDPQX
MC(7.AY]9S,$E%Z H+2FE8=[L6_.M&;,T-TP#%Q=IW80S810:>6?1P0DBPO1<
M'\#3?TS&V!D,XZ+(O$8IV$+[+09@0&6<I:"(V(_'0K>EZ2ULS36I1..P3=_<
MDPB[WH#?,1Z]9*V$Z\[!@UHGB!-=Q< ^9;)A0+%3PNI2:%VH7<?8L%=D6NS=
MG1DQ2U#8K26_<*K#'J8].V(S13M*]-<,;#RRE ,J6F+A*,-SY.*O\ 0$&!Z<
M1<Q)729M<6X>-2"U%YP.BE*- B,$0Y]_!LF[Z22ZG<A%+^T]F$0__GI"%?S'
M0Z3<?;+I\>)L*YP_I0P_/>.\:I!_D.8@%#+I>XPN4X%N[UV9JJN7L<'N5_!O
M,%HOJ"JH<J4:B6BTUG!F5B;M WR9!(MS>Z'\*-+V*97BSR7%FE8E]41M03LB
MW0NE(TB*TH=\#@TD2&JLD'6H"HQVF6?9S*9CE(I5<G[*P-AJA<0L\T"E6QP=
M'-).G>S!(P^>/'T1'3Q[=+#S;K*GANN?!3U6'&.M'!BP1LH\+Z\SKX>ZG?I,
M'L3&I>HLP^<0)Y9I'KM88N(;IW"R]_/>F9W"X>/#O6>'<-A?D)L4==Z/N9?[
M>_MXY+_^T=.](WHYEX_TKL+/;T\_VA(</3O<PQ70V^B=WNTES@ZK)5KB6-UB
M5'I[#F)<IT-<(QSK 24\G1N@QSVL)+OB:&Q^SZLWZ;.?N$TP7 -@F-%8CV>-
M0F$8LY:@,<MU?N&H_T1I8VF^\[[/$:X3G9X:'?13.9_O_@Q/?A?]2?0.#:@W
M6/.4 M\)]VVKP1 D[&4CRN%V8_B"@Z*/O@9%[]4.?R)=(2DSCDY-_2)ZZ?H[
MOR5N!?! 4&1.?VA%1PWO'!]V=(.N">: Q=M,=F4>&MM#Q7 N1S^&AFYV@7P"
ML:K82FQ:C\K8^&C49C!"CTD>VEQ2*WS[VP0@/0$-F&K-]=4_J01J4DB"$$;M
M04 P&&.K]FW\U<S3P(L6R:S.8#T14.&6:IED.6,#.=.$EK>E[6:0+C88'BKB
M:Q6IF)DI_#%'R^RZ1G5IDIOI/ 2#55" M1 L7X&TS?,;]3NV./D#!=+*I+<I
M\<B(6;(7'?,"V4"F6X'QR&Y0M,-I1+P,[*9:U$%(OCCB@/Y@-9?F;Z_W_KDG
M"(7S=';9N@2.]@]VC_:?3UCO+]D19O<+K4/</[* ;=C 7^Q)URMKL^V1"-&B
M&)?1263BA)'99=X[B]-?'XSQ/X!__93.];&;\ZOD>C"3[AG. DG$TQ.\FME4
MH^L;:^2UC?W6&-1FNQ]@\L]H\F_74SE_TN(6A>)_%=O<BPC6!ZL]3$W;,;5V
M(J%_R^B=0%_4+1!'K\MB%XT.DT0-Q9"RJDJORAFS8N)(F]HHG8T)VP*>;[&T
MYB6:1\^$;%M 'YB7[P(9HP94"BH34$S"WT#A62EGL0_9H5U7_/,6)G."O_<X
MYR.4)HD0($K& =LU^2;'786+F>$+FK;8#SG<.HO5S\/='ZN-=O"BBCUOZXP#
MCL0W+4/W"73/M]FTVPH%!;[K6(>^,<02BG[+Y0&[1>$""H RK2W?T05S9N-U
MPB!&UG%2$9'<R"I<I<7:8DH"DXZF%5-NF !E(H)C@D$4<G<7%7U'GA-M\1AT
M(^BN4E\@-@9013"V3$"GZ^5>APM"HC#WL@E4-P#WN%LN7,-D1J4#'+6C!DW(
MK2+6Q@4,N) B*'+.X'+@H(_%K$]<;#!T4GD%RLKA]+D0A4Y+77=2+* NTIR.
M#"H.K(%+B>CD0U8!=-H]R2)'!<TJ=;DRN#RV5S'<*=!W+^GB^Q$@$  L>5$+
MF/!%4X.FK##/"<KX!(-DY*2]3L%N!OUZ6LSV8JG/9P@W)0Z>/X]^7<]KTF'H
M"\;1X^_?_F&7QLWSZ6.8-D@?P@SS77(JOH,5^^:'YO+[;^$7/T0_YV59Q5:C
MPW_],P*_Y>"(K&Q,LUX89+? 5W''C P*)C=PHEO9HH$?]^D$-K''([*QR8K'
MBI#&:&IY&*N+B]14G][+=MU)T4HFBG2"A3[A>3<:N!:\6ETR59HZ\OY9%O0A
MX]7O94(*M$+@5RX$,5MCEY#!"99_.9G9K,%]C,(:P$,B%7,TY-Y4MZ.7XYI'
MU= DF9F$MP=CRW*%73??-9DV ZDU7B39%2Y8[C5QP-1[AO<G+[ R+/N*8/:$
M5/=36L;/R3+^7T/<=X)PO&)VPV;NZ<(Q^8F_1U(]Q8PM+I,E_)/#S)=61NQM
M[<5 /81NTGI)M-8N_H7T;@@;@I_+VS4VT[=/YV6>)Y68<R&O>/M3:VV$2OP3
M6VU 3;H<\-9\Q58U!MR? ND@+ 2?I7EN A.M+A"8XG!PJ>#\%&D<+X5=F3Y3
M7.R.*7@ B)%&@CQ$?\U2D>P$V7UD_"VR1M@K*G%A#:IRCF('WX].]<T5WF\C
M"V3B9!;(%BBXVJ(T2XCQBE9]+/[:$]/;2)D4=6/>'9P!*?[,<M$4%8B7M^ V
M5:%)"5OC)(2SGH=,S1I"2VL&^ULO,+!N%[I@RC'\$M13MY)>(Z?A!>H54U(=
MG03:>&1^5Y>*3P(3B-*]*Y%8'=:V2! 0 U/KM$<T E-4! [W?8MPF,=0VJJ#
M(JB-CMQQ+;@K^NBPG&Z>CLFZ6B*J\-)&O2MK4J\?8W'[?S >V?&;"YC::6P9
MS]AJ4\*<%'ZI>G!9*!)Q;TLQZ)M\G%O[<)\K')/WG)4^Q<H1HST4\\*]K740
M)H!X*4VFD+PWP"<,<08ABVA,@!U6,*6K8:"0\@O6F 3;6J[6C='Q\%SFT2BH
MMB?PU!T*?=&I0ZHQ^6*#JX.7GM?_475\M"MEMW(26[$PGP7D@;Z*-FHX; JO
MQQ('@\(BOW9)W' (TTDQ2YB&=;:C8DD7C<I]K)>.9H0"-9>)HVF9UFGQ_]N[
MTJ>VD6W_G2K^AZ[,FU=0)0@V:T(N5880XGO9'I!DIF[=#[+4QIK(DD<+A/O7
MO[-T2ZW%9@F+373KO8FQ)77WZ=/G_,XJPQ:"5<]P,&^]">8]JIQHD9SXS.^*
MRPKGD./Y&WV:8FVB5F,@>< (]!! >.[L0-VGV07'S)=WE".$4FSGD$>@;*,
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M0KEU#0I1,C.0!&1.4%LB@1+A$$X/29Z_4SC=S!](IR@>>#!D?WX.[S!1R?6
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MG:@S_C,YF/+A[>[)QS_AR\\71X<[_P]02P,$%     @ QH-B7%4HV!X3!P
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M:4V+OWB[N1DOV$I$#^V96'$-([Z&B5PQU-3SAH/1>461D95NYZ+KWB_%7*2
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MPB\^YH'L_\B3_\&+TM,.?>P/O^!\_C)O&=.@UWV<-/\3^"]02P,$%     @
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MK1N.%RRF\6ZLR@@_NE(GX.WO9&>+94ER2WA66^$502ZX5@@B89M6@*P$)#5
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MD/_#5LAEM%>:/C;8AU[71^P_^P@GMOP#4$L! A0#%     @ QH-B7":'9B[
M$   *'    X              ( !     &0Q,38S,#ED.&LN:'1M4$L! A0#
M%     @ QH-B7&6&H!HBG   ]&0# !               ( ![!   &0Q,38S
M,#ED97@Q,2YH=&U02P$"% ,4    " #&@V)<52C8'A,'   :&   $
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64$L%!@     &  8 ?0$  )##      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d116309d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lfst-20260225.xsd" xlink:type="simple"/>
    <context id="duration_2026-02-25_to_2026-02-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001845257</identifier>
        </entity>
        <period>
            <startDate>2026-02-25</startDate>
            <endDate>2026-02-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-295">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-02-25_to_2026-02-25"
      id="Hidden_dei_EntityCentralIndexKey">0001845257</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-306">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-307">2026-02-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-308">LifeStance Health Group, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-309">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-310">001-40478</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-311">86-1832801</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-312">4800 N. Scottsdale Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-313">Suite 2500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-314">Scottsdale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-315">AZ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-316">85251</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-317">602</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-318">767-2100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-319">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-320">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-321">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-322">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-323">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-324">LFST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-325">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-02-25_to_2026-02-25" id="ixv-326">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
